Solo para suscripciones Premium:
Empieza tu prueba gratis de 14 días
| Descarga un informe de ejemplo
Te quedan 3 de 3 Checks diarios
Muestra a tus visitantes lo bien optimizado que está tu sitio web con el widget de Seobility. La herramienta presenta la puntuación SEO actual de tu Homepage.
Nombre | Valor |
---|---|
description | UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology. |
generator | Joomla! - Open Source Content Management |
viewport | width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no |
HandheldFriendly | true |
apple-mobile-web-app-capable | YES |
lang | en-gb |
content-type | text/html; charset=UTF-8 |
URL | Atributo ALT | Título |
---|---|---|
...lank/images/[email protected] | UroToday | |
...blank/images/[email protected] | Carece de atributo ALT | |
...nk/images/video-channels/[email protected] | Carece de atributo ALT | |
[email protected] | Carece de atributo ALT | |
...ls/[email protected] | Carece de atributo ALT | |
[email protected] | Carece de atributo ALT | |
...mages/conferences-images/[email protected] | Carece de atributo ALT | |
...s/conferences-images/[email protected] | Carece de atributo ALT | |
...mages/[email protected] | Carece de atributo ALT | |
...-images/[email protected] | Carece de atributo ALT |
Jerarquía de encabezados | Contenido |
---|---|
H2 | Videos |
H2 | Recent Conference Coverage |
H2 | Recent Physician-Scientist Review Articles |
H2 | Transformative Evidence |
H2 | Trials in Progress |
H3 | AUA 2025 |
H3 | Leaders in Radiopharmaceuticals: Disruptive Innovations and Personal Perspectives |
H3 | PSMA and Beyond 2025 |
H3 | ESMO 2024 Quick Takes |
H4 | Featured Videos |
H4 | Genomic Classifier in Prostate Cancer: High-Risk |
H4 | High-Risk Non-Muscle Invasive Bladder Cancer |
H4 | Advanced Bladder Cancer |
H4 | Integrating (177Lu)–PSMA-617: A Practical Approach for Urology Clinics |
H4 | Beyond Androgen Blockade - Exploring New Pathways for Treating mCRPC and mHSPC |
H4 | APCCC 2024 |
H4 | Latest Videos |
H4 | EMBARK |
H4 | Login |
Enlace | Propiedades | Texto ancla |
---|---|---|
/privacy-policy.html | Privacy Policy | |
https://www.urotoday.com/ | UroToday IMG-ALT UroToday A-TITLE UroToday | |
/contact-us.html | Contact | |
/SimpleSignOn.modal | Login | |
/register.html | Sign Up Free | |
/peace-3-te.html | PEACE-3 Trial | |
/transformative-evidence/profo... | PROfound Trial | |
/transformative-evidence/ralu-... | The RALU Study: Treatment Considerations in the First Line Setting of mCRPC | |
/transformative-evidence/visio... | VISION Trial | |
/aranote-te.html | ARANOTE Trial | |
/transformative-evidence/the-a... | ARASENS Trial | |
/transformative-evidence/arami... | ARAMIS Trial | |
/transformative-evidence/embar... | EMBARK Trial | |
/transformative-evidence/cobra... | COBRA Trial | |
/transformative-evidence/clini... | CONDOR Trial | |
/transformative-evidence/clini... | OSPREY Trial | |
/n-803-te.html | ANKTIVA® | |
/transformative-evidence/bladd... | Bladder Cancer Detection | |
/transformative-evidence/core-... | CORE-001 Study | |
/ev-302-te.html | EV-302 | |
/video-lectures/immunotherapy-... | Immunotherapy in NMIBC | |
/centers-of-excellence.html | Centers of Excellence | |
/center-of-excellence/health-p... | Health Policy | |
/center-of-excellence/bladder-... | Bladder Cancer Ashish Kamat, MD A-TITLE Ashish Kamat, MD | |
/center-of-excellence/advanced... | Advanced Bladder Cancer Shilpa Gupta, MD A-TITLE Shilpa Gupta, MD | |
/center-of-excellence/trimodal... | Trimodality Therapy Leslie Ballas, MD A-TITLE Leslie Ballas, MD | |
/center-of-excellence/advanced... | Advanced Kidney Cancer Pedro Barata, MD, MSc A-TITLE Pedro Barata, MD, MSc | |
/center-of-excellence/kidney-c... | Endourology Jaime Landman, MD A-TITLE Jaime Landman, MD | |
/center-of-excellence/localize... | Localized Prostate Cancer Matthew R. Cooperberg, MD, MPH A-TITLE Matthew R. Cooperberg, MD, MPH | |
/center-of-excellence/decipher... | Decipher® Genomic Classifier | |
/center-of-excellence/imaging-... | Imaging Center Phillip Koo, MD A-TITLE Phillip Koo, MD | |
/center-of-excellence/mhspc.html | mHSPC Neeraj Agarwal, FASCO, MD A-TITLE Neeraj Agarwal, FASCO, MD | |
/center-of-excellence/nmcrpc.html | nmCRPC Zachary Klaassen, MD, MSc A-TITLE Zachary Klaassen, MD, MSc | |
/center-of-excellence/mcrpc-tr... | mCRPC Treatment A. Oliver Sartor, MD A-TITLE A. Oliver Sartor, MD | |
/center-of-excellence/mcrpc-wi... | mCRPC with Bone Metastasis | |
/center-of-excellence/psma-tar... | PSMA-Targeted Therapy | |
/center-of-excellence/advanced... | Advanced Prostate Cancer Zachary Klaassen, MD, MSc A-TITLE Zachary Klaassen, MD, MSc | |
/center-of-excellence/disparit... | Disparities: Social Determinants of Health Samuel L. Washington III, MD, MAS A-TITLE Samuel L. Washington III, MD, MAS | |
/center-of-excellence/translat... | Translational Science in Prostate Cancer Andrea Miyahira, Ph.D A-TITLE Andrea Miyahira, Ph.D | |
/center-of-excellence/women-in... | Women in Science Andrea Miyahira, Ph.D A-TITLE Andrea Miyahira, Ph.D | |
/center-of-excellence/upper-tr... | Upper Tract Urothelial Carcinoma Sam S. Chang, MD, MBA A-TITLE Sam S. Chang, MD, MBA | |
/center-of-excellence/testicul... | Testicular Cancer | |
/center-of-excellence/bladder-... | Bladder Health | |
/center-of-excellence/cauti.html | Urologic Catheters (Includes CAUTI) | |
/video-lectures.html | Videos | |
/video-lectures/conferences.html | Conferences | |
/video-lectures/exclusive-coll... | Exclusive Collaborations | |
/video-lectures/independent-ed... | Independent Medical Education | |
/video-lectures/covid-19.html | Covid-19 | |
/video-lectures/the-prostate-c... | The Prostate Cancer Foundation | |
/health-policy-in-urological-d... | Health Policy in Urological Diseases | |
/video-lectures/disparities-so... | Disparities: Social Determinants of Health | |
/video-lectures/practice-guide... | Practice Guidelines Reviews | |
/video-lectures/urologic-oncol... | Prostate Cancer | |
/video-lectures/urologic-oncol... | Bladder Cancer | |
/video-lectures/urologic-oncol... | Kidney Cancer | |
/video-lectures/urologic-oncol... | Upper Tract Urothelial Tumors | |
/video-lectures/urologic-oncol... | Texto duplicado | Testicular Cancer |
/video-lectures/endourology-to... | Endourology | |
/video-lectures/pelvic-health-... | Pelvic Health & Reconstruction | |
/actionable-clinical-data/lg-i... | LG-IR NMIBC | |
/actionable-clinical-data/adst... | Adstiladrin® | |
/actionable-clinical-data/zirc... | ZIRCON | |
/trials-in-progress/bond-003-c... | BOND-003 Cohort P | |
/trials-in-progress/core-008-t... | CORE-008 | |
/trials-in-progress/immortal-t... | IMMORTAL | |
/trials-in-progress/pivot-006-... | PIVOT-006 | |
/trials-in-progress/radical-tr... | RadiCal | |
/trials-in-progress/samurai-tr... | SAMURAI | |
/trials-in-progress/aramon-tri... | ARAMON | |
/trials-in-progress/arasec-tri... | ARASEC | |
/trials-in-progress/arastep-tr... | ARASTEP | |
/trials-in-progress/clarify-tr... | CLARIFY | |
/trials-in-progress/eclipse-tr... | ECLIPSE | |
/trials-in-progress/escape-tri... | ESCAPE | |
/trials-in-progress/fort-trial... | FORT | |
/trials-in-progress/metanova-t... | METANOVA | |
/trials-in-progress/nrg-gu010-... | NRG-GU 0101 | |
/trials-in-progress/promise-pc... | PROMISE | |
/trials-in-progress/rtire-tria... | RTIRE | |
/trials-in-progress/secure-tri... | SECuRE | |
/trials-in-progress/shorter-tr... | SHORTER | |
/clinical-trials.html | Clinical Trials | |
/clinical-trials.html | Search Clinical Trials | |
/articles/urology-benign-and-m... | Urologic Oncology | |
/articles/urology-benign-and-m... | Men's Health | |
/articles/urology-benign-and-m... | Endourology & Stones | |
/pediatric-urology.html | Pediatric Urology | |
/covid-19-and-genitourinary-ca... | COVID-19 and Genitourinary Cancers | |
/articles/pelvic-health/pelvic... | Texto duplicado | Pelvic Health & Reconstruction |
/conference-coverage.html | Conference Coverage | |
/conference-highlights/aua-202... | AUA 2025 | |
/conference-highlights/2025-uc... | PSMA and Beyond 2025 Conference | |
/conference-highlights/eau-202... | EAU 2025 | |
/conference-highlights/ses-aua... | SES AUA 2025 | |
/conference-highlights/2025-gu... | Thought Leaders 2025 | |
/conference-coverage.html | View All | |
/video-lectures/european-socie... | ESMO 2024 | |
https://www.urotoday.com/pcf.html | PCF | |
https://www.urotoday.com/ | Sin texto | |
/video-lectures.html | View all | |
/video-lectures/aua-2025.html | Sin texto | |
/transformative-evidence/bladd... | Real-World Data Improves NMIBC Risk Assessment with Blue Light Technology - Siamak Daneshmand & Boris Gershman | |
/video-lectures/aua-2025/video... | Platform Reduces Unnecessary Cystoscopies for Hematuria Patients - John Sfakianos | |
/aranote-te/videos/4807-aranot... | ARANOTE Study Shows Benefits of Deep PSA Response with Darolutamide - Neal Shore | |
/video-lectures/aua-2025.html | View all AUA 2025 videos | |
/video-lectures/leaders-in-rad... | Sin texto | |
/video-lectures/leaders-in-rad... | Imaging the Immune System: CD8 T-Cell Tracking for Cancer and Autoimmune Disease - Anna Wu | |
/video-lectures/leaders-in-rad... | Covalent Radioligands Advance Precision in Tumor Targeting - Andreas Goutopoulos | |
/video-lectures/leaders-in-rad... | Lead-212 Radiopharmaceuticals Offer Promise in Targeted Cancer Treatment - Volker Wagner | |
/video-lectures/leaders-in-rad... | View all Leaders in Radiopharmaceuticals: Disruptive Innovations and Personal Perspectives videos | |
/video-lectures/2025-ucsf-ucla... | Sin texto | |
/video-lectures/2025-ucsf-ucla... | Comparing Post-Treatment SPECT to PSMA PET for Radioligand Therapy Monitoring "Presentation" - Thomas Hope | |
/video-lectures/2025-ucsf-ucla... | Improving Outcomes with Combination Therapies for PSMA Radioligand Treatment "Presentation" - Michael Hofman | |
/video-lectures/2025-ucsf-ucla... | FAP and Nectin-4 Targeted Imaging and Therapy in Urothelial Cancer "Presentation" - Vadim Koshkin | |
/video-lectures/2025-ucsf-ucla... | View all PSMA and Beyond 2025 videos | |
/video-lectures/european-socie... | Sin texto | |
/video-lectures/european-socie... | Prostate Cancer QuickTakes ESMO 2024 - ARANOTE, PEACE-3, and SPLASH Trials - Oliver Sartor | |
/video-lectures/european-socie... | View all ESMO 2024 Quick Takes videos | |
/video-lectures/aua-2025/video... | Sasanlimab + BCG Improves Event-Free Survival in High-Risk NMIBC: CREST Study Results - Neal Shore | |
/video-lectures/aua-2025/video... | Evaluating Risk Stratification Models for Blue Light Cystoscopy in Bladder Cancer - Sia Daneshmand & Boris Gershman | |
/actionable-clinical-data/adst... | Streamlining Intravesical Therapy: Practical Insights for BCG-Unresponsive NMIBC - Patrick Hensley | |
/video-lectures/bladder-cancer... | Advancing Microhematuria Evaluation: The Impact of Urinary Biomarkers and Updated Guidelines - Jay D. Raman & Yair Lotan | |
/actionable-clinical-data/lg-i... | Refining Risk in NMIBC: Intermediate Stratification, TURBT Quality, and Emerging Options - Katie Murray | |
/video-lectures/aua-2025/video... | The Details Are in the Core: Advancing Prostate Tissue Collection - James Wysock | |
/video-lectures/embark-trial/v... | EMBARK Trial: Treatment Options for High-Risk Biochemical Recurrence - Neal Shore | |
/video-lectures/practical-aspe... | First Patient Treated with Pluvicto™ in Pre-Chemotherapy Setting Following FDA Approval - Steven Finkelstein | |
/video-lectures/eau-2025/video... | Cretostimogene Grenadenorepvec Complete Response in BOND-003 Cohort C - Trinity Bivalacqua | |
/video-lectures/asco-gu-2025/v... | LEGEND Trial: EG-70 in BCG-Refractory Non-Muscle Invasive Bladder Cancer - John Taylor | |
/video-lectures/psma-targetedt... | FDA Approval of 177Lu-PSMA-617 for Taxane-Naive mCRPC - Oliver Sartor | |
/video-lectures/advanced-bladd... | A Case-Based Discussion on First-Line EV + Pembrolizumab for Metastatic Urothelial Carcinoma - Neal Shore | |
/actionable-clinical-data/lg-i... | ENVISION Trial Evaluates UGN-102 for Recurrent Low-Grade NMIBC Bladder Cancer - Sandip Prasad | |
/video-lectures/asco-gu-2025/v... | PREDICT Trial Investigates Biomarker-Guided Treatment for Advanced Prostate Cancer - Rana McKay | |
/video-lectures/localized-pros... | Advanced Imaging for Focal Therapy in Intermediate Risk Prostate Cancer - Matthew Cooperberg | |
/video-lectures/mcrpc-treatmen... | Revisiting HER2 as a Therapeutic Target in Prostate Cancer - Nicole Mavingire | |
/video-lectures/asco-gu-2025/v... | Real-World Data on Treatment Patterns After PSMA-Targeted Therapy in mCRPC - Oliver Sartor | |
/video-lectures/asco-gu-2025/v... | Phase II ENZA-p Trial Explores Effect of Lutetium PSMA With Enzalutamide - Louise Emmett | |
/video-lectures/asco-gu-2025/v... | Cretostimogene Expanded Access Program for BCG-Unresponsive Bladder Cancer - Sarah Psutka | |
/video-lectures/asco-gu-2025/v... | Real-World Safety Profiles of First-Line Therapies for Advanced Urothelial Carcinoma - Amanda Nizam | |
/video-lectures/asco-gu-2025/v... | Adjuvant Nivolumab in High-Risk Muscle Invasive Bladder Cancer Analysis Shows Improved Outcomes for Patients: CheckMate 274 - Matthew Galsky | |
/video-lectures/asco-gu-2025/v... | Registry Data Shows Risk Migration With Blue Light Cystoscopy - Alireza Ghoreifi & Siamak Daneshmand | |
/video-lectures/asco-gu-2025/v... | ARANOTE Trial Explores Darolutamide’s Role in High and Low-Volume Metastatic Prostate Cancer - Fred Saad | |
/video-lectures/asco-gu-2025/v... | ABLE-32 Trial Explores Nadofaragene Firadenovec for Intermediate-Risk NMIBC - Neal Shore | |
/actionable-clinical-data/adst... | Real-World Data on Nadofarogene Firadenovec for BCG-Unresponsive Bladder Cancer - Mark Tyson & Jacob Moyer | |
/video-lectures/mhspc/video/me... | Physician Decision Making & Combination Therapies in Metastatic Prostate Cancer - Neeraj Agarwal | |
/video-lectures/managing-renal... | Advancing Imaging Techniques for Indeterminate Renal Mass Diagnosis and Clinical Decision-Making - Sam Chang | |
/video-lectures/localized-pros... | CLARIFY Trial: Multiday 64Cu-SAR-bisPSMA PET Scans Refine Prostate Cancer Assessment - Luke Nordquist | |
/video-lectures/lower-urinary-... | RISE FOR HEALTH Study on Female Bladder Health - Ariana Smith | |
/video-lectures/suo-2024/video... | Utilizing Telehealth to Improve Access of Care of Patients with Bladder Cancer - Tracey Krupski | |
/video-lectures/suo-2024/video... | Integrating Genomic Testing with MRI Enhances Stratification of Surveillance Patients - Eric Kim & Mark Sultan | |
/video-lectures/suo-2024/video... | Advancing Treatment for BCG-Unresponsive Bladder Cancer - Eugene Pietzak | |
/video-lectures/suo-2024/video... | Emerging Neoadjuvant Combinations for Muscle-Invasive Bladder Cancer - Mamta Parikh | |
/video-lectures/suo-2024/video... | PIVOT-006: Phase III Trial of Creto vs Surveillance in Intermediate-Risk Bladder Cancer - Mark Tyson | |
/video-lectures/suo-2024/video... | BCG Unresponsive Bladder Cancer in 2024 - Ashish Kamat | |
/video-lectures/suo-2024/video... | BOND-003 Trial Results in BCG Unresponsive Non-muscle Invasive Bladder Cancer - Mark Tyson | |
/video-lectures/esmo-2024/vide... | 5-Year Survival Outcomes in Cisplatin-Ineligible Patients from EV-103 - Jonathan Rosenberg | |
/video-lectures/esmo-2024/vide... | Nectin-4 Expression Not Predictive of Response in Enfortumab Vedotin Therapy - Thomas Powles | |
/video-lectures/journal-club/v... | Radium-223 Plus Enzalutamide Improves Survival in mCRPC: PEACE-3 Trial Results, Journal Club - Rashid Sayyid & Zachary Klaassen | |
/actionable-clinical-data/adst... | 36-Month Efficacy of Nadofaragene in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer - Yair Lotan | |
/video-lectures/south-central-... | BRAVO Trial Highlights Improved Detection Reduces Bladder Cancer Recurrence - Ali Nasrallah | |
/video-lectures/esmo-2024/vide... | Belzutifan vs Everolimus Trial Data in Advanced RCC Care - Brian Rini | |
/video-lectures/artificial-int... | AI-Powered Prostate Cancer Risk Assessment Tool Validated for Low-risk and Active Surveillance - Andre Esteva | |
/video-lectures/advanced-bladd... | SWOG Trial On Standard vs Extended Lymphadenectomy in Muscle Invasive Bladder Cancer - Seth Lerner | |
/video-lectures/esmo-2024/vide... | NIAGARA Trial: Chemo Plus Durvalumab Improves Survival in Muscle-Invasive Bladder Cancer - Thomas Powles | |
/video-lectures/esmo-2024/vide... | Advancing mHSPC Treatment Options: ARANOTE Trial Analysis - Neal Shore & Fred Saad | |
/video-lectures/genomic-classi... | Decipher® in mHSPC: Guiding Risk Assessment and Treatment Intensification - Gerhardt Attard | |
/video-lectures/localized-pros... | Radiation Therapy Options for Localized Prostate Cancer Compared in Major Trial - Jason Efstathiou | |
/video-lectures/esmo-2024/vide... | PEACE 3 Trial Results Show Promise for Radium-223 and Enzalutamide in Asymptomatic mCRPC - Fred Saad | |
/video-lectures/localized-pros... | Proton Therapy vs IMRT in Prostate Cancer PARTIQoL Trial - Jason Efstathiou | |
/video-lectures/high-risk-non-... | SunRISe-1 Trial Advances Bladder Cancer Treatment with TAR-200 - Michiel Van der Heijden | |
/video-lectures/mcrpc-treatmen... | RAPSON Trial Explores Radium223 and Docetaxel Sequencing in mCRPC - Vincenza Conteduca | |
/video-lectures/esmo-2024/vide... | Darolutamide Improves Outcomes for mHSPC Patients in ARANOTE Trial - Fred Saad | |
/video-lectures/nccn-prostate-... | Medicare Part D 2025 Reduces Out-of-Pocket Costs for Oral Prostate Cancer Treatments - David Morris | |
/video-lectures/navigating-can... | Financial Distress for GU Cancer Patients: Insights from CDC Survey - Laura Bukavina & Steven Leonard | |
/video-lectures/navigating-can... | Cancer-Related Financial Hardship Among Cancer Survivors: Research from the HINTS-SEER Survey - Apoorv Dhir & Rishi Sekar | |
/video-lectures/localized-pros... | PARTIQoL Trial: Proton Therapy vs IMRT for Localized Prostate Cancer - Jason Efstathiou | |
/video-lectures/genomic-classi... | Utilizing the Decipher® mRNA Score for Risk Stratification in mHSPC - David Morris and Ashley Ross | |
/video-lectures/esmo-2024/vide... | PEACE-3 Trial Results: Radium-223 + Enzalutamide in mCRPC - Bertrand Tombal | |
/video-lectures/esmo-2024/vide... | UpFrontPSMA Trial: Lutetium-PSMA + Docetaxel in mHSPC - Arun Azad | |
/video-lectures/esmo-2024/vide... | EMBARK Trial: Age-Stratified Analysis of Enzalutamide in High-Risk Biochemically Recurrent Prostate Cancer - Neal Shore | |
/video-lectures/esmo-2024/vide... | ARANOTE Study: Transforming Metastatic Hormone Sensitive Prostate Cancer Treatment - Fred Saad | |
/video-lectures/esmo-2024/vide... | PEACE-1 Trial Reveals Key Genomic Alterations Linked to Survival in Prostate Cancer Patients - Cédric Pobel | |
/video-lectures/esmo-2024/vide... | SunRISe-4 Trial Explores TAR-200 and Cetrelimab Combination for Bladder Cancer Treatment - Andrea Necchi | |
/video-lectures/esmo-2024/vide... | Fecal Microbiota Transplant Boosts Immunotherapy in Metastatic Renal Cell Carcinoma in TACITO-II Trial - Chiara Ciccarese | |
/video-lectures/esmo-2024/vide... | Disitamab Vedotin: Promising HER2-Targeted Therapy for Urothelial Cancer - Matthew Galsky | |
/video-lectures/esmo-2024/vide... | PRINCE Trial Highlights Early Detection of Prostate Cancer Progression with PSMA PET-CT - Michael Hofman | |
/video-lectures/esmo-2024/vide... | COTRIMS Trial Shows High Cure Rates with RPLND in Stage IIA/B Seminoma - Axel Heidenreich | |
/video-lectures/esmo-2024/vide... | AMBASSADOR Trial: Extended Follow-up on Adjuvant Pembrolizumab in Bladder Cancer - Andrea Apolo | |
/video-lectures/esmo-2024/vide... | SPLASH Trial Highlights Radiopharmaceutical Lutetium-177’s Role in Advanced Prostate Cancer Treatment - Oliver Sartor | |
/video-lectures/esmo-2024/vide... | TiNivo-2 Trial Results in Advanced Renal Cell Carcinoma Treatment - Toni Choueiri | |
/video-lectures/esmo-2024/vide... | Genetic Profiles in Early vs. Late Stage Urothelial Cancer - Dag Stormoen | |
/video-lectures/bcan-think-tan... | Patient Perspectives on Bladder Cancer: Balancing Treatment Options and Shared Decision-Making - Roger Li | |
/video-lectures/journal-club/v... | Cardiovascular Risks of ARSIs in Prostate Cancer: Meta-Analysis Findings, Journal Club - Rashid Sayyid & Zachary Klaassen | |
/video-lectures/lower-urinary-... | The Rise of FRU: How Functional Urology Intersects with Reconstructive Urology - Brian J. Flynn | |
/video-lectures/localized-pros... | Transperineal vs Transrectal Prostate Biopsy: Trial Findings and Discussion - Badar Mian | |
/video-lectures/endourology-to... | Robotic Mini-PCNL and Ureteroscopy: Advancing Kidney Stone Treatment "Presentation" - Jaime Landman | |
/video-lectures/pet-psma-imagi... | Phase 3 CLARIFY Trial Investigates 64Cu-SAR-bisPSMA PET for Improved Prostate Cancer Detection - Louise Emmett | |
/video-lectures/pet-psma-imagi... | CLARIFY Trial: Advancing Prostate Cancer Imaging with 64Cu-SAR-bisPSMA PET - Neal Shore | |
/video-lectures/lower-urinary-... | COURAGE Trial: Vibegron for BPH Patients with Persistent OAB Symptoms - David Staskin | |
/video-lectures/advanced-bladd... | EV-302 Trial Establishes Treatment Standard for Urothelial Carcinoma - Daniel Petrylak | |
/video-lectures/mcrpc-treatmen... | Overcoming Hormone Resistance: ARV-766 in Advanced Prostate Cancer - Daniel Petrylak | |
/video-lectures/leaders-in-rad... | Radiopharmaceuticals and Combination Approaches in Advancing the Prostate Cancer Treatment Landscape - Philip Kantoff | |
/video-lectures/the-prostate-c... | Extracellular Vesicles in Prostate Cancer: Multi-Omic Liquid Biopsy - Irene Casanova-Salas & Joaquin Mateo | |
/video-lectures/cancer-or-not-... | Reservations About a Nomenclature Change for Gleason Grade 1 Prostate Cancer "Presentation" - Adam Kibel | |
/video-lectures/bladder-cancer... | Trimodal Therapy in Urothelial vs Non-Urothelial Bladder Cancer - Mario de Angelis | |
/video-lectures/precision-medi... | Cell Surface Targets in mCRPC: Expression Landscape and Therapeutic Potential - Michael Haffner | |
/video-lectures/clinical-trial... | Urologic Oncology Clinical Trials: Size, Scope, and Impact - Kristian Stensland | |
/video-lectures/bladder-health... | Oxybutynin-Associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment - Beyond the Abstract | |
/video-lectures/navigating-can... | Reducing Prescription Drug Costs: 4 Online Tools for Urology Patients - Benjamin Pockros | |
/video-lectures/upper-tract-ur... | FGFR3 Inhibition for Upper Tract Urothelial Cancer: Phase 1b Trial Results - Surena Matin | |
/video-lectures/advanced-kidne... | Durvalumab Plus Guadecitabine in Metastatic Kidney Cancer: Phase 1/2 Trial Results - Yousef Zakharia | |
/video-lectures/asco-2024/vide... | PSMAfore Trial: Lutetium PSMA's Impact on mCRPC Quality of Life - Karim Fizazi | |
/video-lectures/health-policy-... | Post-Prostatectomy Care: Variability in Treatment for Lymph Node Positive Prostate Cancer - Daniel Triner | |
/video-lectures/bladder-cancer... | dMMR and MSI-H in Urothelial Carcinoma: Prevalence and Treatment Implications - Elias Chandran | |
/video-lectures/mcrpc-treatmen... | Meta-Analysis Evaluates Cardiovascular Risks of AR Inhibitors in Prostate Cancer - Omar El-Taji & Ashwin Sachdeva | |
/video-lectures/renal-cancer/v... | Functional Renal Imaging and Advances in Kidney Cancer Detection - Shankar Siva | |
/video-lectures/asco-2024/vide... | CYCLONE 2 Trial Results: Abemaciclib in Metastatic Castration-Resistant Prostate Cancer - Matthew Smith | |
/video-lectures/women-in-scien... | Breaking Barriers in Cancer Treatment and Women's Leadership in Oncology - Ulka Vaishampayan | |
/video-lectures/the-prostate-c... | PSCA CAR T-Cell Therapy for Metastatic CRPC: Phase 1 Trial Results - Tanya Dorff | |
/video-lectures/the-prostate-c... | Mental Health and Prostate Cancer in the Veterans Population - Zachary Klaassen | |
/video-lectures/genomic-classi... | 2024 NCCN Guidelines: Simplifying the Management of Very Low-Risk Prostate Cancer - Rashid Sayyid & Zachary Klaassen | |
/video-lectures/bladder-cancer... | Bladder-Sparing Chemoradiation for Localized Bladder Cancer: Addressing the Unmet Need - Brent Rose | |
/video-lectures/aua-2024/video... | SunRISe-5 Trial: Evaluating TAR-200 for Recurrent High-Risk Non-Muscle Invasive Bladder Cancer - Sima Porten | |
/video-lectures/advanced-prost... | IMPLEMENT Study: Addressing the Underutilization of Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer - Stacy Loeb | |
/video-lectures/advanced-prost... | Machine Learning Model Predicts Overall Survival in Metastatic Prostate Cancer - Ali Sabbagh | |
/video-lectures/precision-medi... | Tarlatamab Shows Encouraging Activity in Phase 1 Trial in DLL3-Positive Neuroendocrine Prostate Cancer - Rahul Aggarwal | |
/video-lectures/the-prostate-c... | ctDNA Fraction Predicts Response to Lutetium PSMA in TheraP Trial for mCRPC - Edmond Kwan | |
/video-lectures/asco-2024/vide... | ARAMIS Trial: PSA Responses with Darolutamide Linked to Minimal Radiographic Progression - Alicia Morgans | |
/video-lectures/non-muscle-inv... | Bridging the Gap in Microhematuria Evaluation: A Discussion on the STRATA Trial - Yair Lotan | |
/video-lectures/mhspc/video/me... | Prognostic Power of Multi-Modal Artificial Intelligence Biomarker in CHAARTED Trial Subset - Mark Markowski | |
/video-lectures/mcrpc-treatmen... | OASIS Project Highlights the Survival Benefits of Rapid PSA Decline with Apalutamide in Prostate Cancer - Benjamin Maughan | |
/video-lectures/mcrpc-treatmen... | Integrating Genetic Variants and Clinical Factors for Improved Prostate Cancer Prognostication - Susan Halabi | |
/video-lectures/advanced-prost... | COBRA Trial: Evaluating 64Cu-SAR-bisPSMA PET Imaging for Prostate Cancer Detection - Phillip Koo | |
/video-lectures/advanced-prost... | Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-Resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Re... | |
/video-lectures/advanced-bladd... | Antibody-Drug Conjugates in Advanced Urothelial Cancer: Current Landscape and Future Directions - Matthew Galsky & Neal Shore | |
/video-lectures/asco-2024/vide... | CORE-001 Study Demonstrates Promising Results for Bladder Cancer with Cretostimogene Grenadenorepvec and Pembrolizumab - Trinity Bivalacqua & Roger Li | |
/video-lectures/localized-pros... | Prostate Cancer Knowledge and Screening Barriers in Northern Tanzania: A Community-Based Study - Blandina Mmbaga & Nicholas Ngowi | |
/video-lectures/bladder-cancer... | Apalutamide for Preventing Bladder Cancer Recurrence: A Proof-of-Principle Trial - Edward Messing | |
/video-lectures/advanced-prost... | UCHL1: A Potential Biomarker and Therapeutic Target for Neuroendocrine Prostate Cancer - Tanya Stoyanova | |
/video-lectures/disparities-so... | Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care Systems - Isla Garraway | |
/video-lectures/apccc-2024/vid... | Escalation Strategies for Suboptimal PSA Decline in mHSPC - Mary-Ellen Taplin | |
/video-lectures/localized-pros... | Testosterone Recovery After ADT: Timing, Predictive Factors, and Clinical Implications - Pierre Blanchard | |
/video-lectures/advanced-prost... | Personalizing Salvage Radiation and Hormone Therapy for Biochemical Recurrence - Daniel Spratt | |
/video-lectures/imaging-prosta... | COBRA Trial Shows Promise for 64Cu-SAR-bisPSMA PET in Biochemical Recurrence - Neal Shore | |
/video-lectures/non-muscle-inv... | Innovative Trials Highlight Progress in Treating Urothelial Carcinoma at AUA 2024 - Karim Chamie | |
/video-lectures/apccc-2024/vid... | Managing Frail Patients with Metastatic Hormone-Sensitive Prostate Cancer - Maria De Santis | |
/video-lectures/lower-urinary-... | Risk Classification for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Using Machine Learning Based Predictions - Beyond the Abstract | |
/video-lectures/apccc-2024/vid... | The Use of PARP Inhibitors in mCRPC with BRCA1/2 Alterations - Joaquin Mateo | |
/video-lectures/bladder-cancer... | Balancing Bladder Preservation with Effective Treatment in Cancer Care - Petros Grivas | |
/video-lectures/ibcg-aua-2024-... | Treatment Options for Advanced Urothelial Cancer Post-EV-302 - Shilpa Gupta & Karima Oualla | |
/video-lectures/non-muscle-inv... | Integrating Nadofaragene Firadenovec into Clinical Practice for Non-Muscle Invasive Bladder Cancer Treatment - Ashish Kamat | |
/video-lectures/treatments-in-... | BOND-003 Trial: Cretostimogene Grenadenorepvec Shows Promise in BCG-Unresponsive NMIBC - Mark Tyson | |
/video-lectures/aua-2024/video... | VA BRAVO 2 Study: Blue Light Cystoscopy Improves Outcomes in NMIBC Patients in Equal Access Setting - Stephen B Williams | |
/video-lectures/non-muscle-inv... | Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer AUA/SUO Guideline - 2024 Amendment - Jeffrey Holzbeierlein | |
/video-lectures/eau-2024/video... | Navigating the Shift to Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Cancer: Key Considerations for Clinicians - Cora Sternberg | |
/video-lectures/eau-2024/video... | Darolutamide Outcomes in European Patients with Metastatic Hormone-Sensitive Prostate Cancer from the ARASENS Trial - Bertrand Tombal | |
/video-lectures/advanced-bladd... | Preclinical Study Evaluates Enfortumab Vedotin and Sacituzumab Govitecan with Radiation for Bladder Cancer - Kent Mouw | |
/video-lectures/eau-2024/video... | Local Therapy in mHSPC: Who Does Really Benefit? - Alberto Bossi | |
/video-lectures/advanced-bladd... | Genomic Tumor Correlates of Response to Trimodal Therapy for Muscle-Invasive Bladder Cancer - Sophia Kamran | |
/video-lectures/embark-trial/v... | The Impact of the EMBARK Trial on Treatment Decisions in High-Risk Biochemical Recurrent Prostate Cancer - Neal Shore | |
/video-lectures/disparities-so... | The Future State of Race & Ethnicity in Urology: Urology Workforce Projection from 2021-2061 - Efe Chantal Ghanney Simons & Ashley Appleton | |
/video-lectures/prostate-cance... | A Phase I Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy - Beyond the Abstract | |
/video-lectures/localized-pros... | Novel 18-Gene Urine Test Improves Detection of Clinically Significant Prostate Cancer - Jeffrey Tosoian | |
/video-lectures/non-muscle-inv... | Patient-Driven Outcomes in the CISTO Trial for High-Grade Non-Muscle Invasive Bladder Cancer - Angela Smith & John Gore | |
/video-lectures/enhancing-andr... | Non-Metastatic Castration-Resistant Prostate Cancer in the Era of PSMA PET Imaging - Aaron Berger | |
/video-lectures/the-continuum-... | Maximizing Survival in Metastatic Hormone-Sensitive Prostate Cancer: The Role of Triplet Therapy - Kelvin Moses | |
/video-lectures/the-continuum-... | Teamwork and Trust: Keys to Seamless Prostate Cancer Care Across Specialties - Paul Eber & Brad Somer | |
/video-lectures/the-continuum-... | Best Practices for Successfully Implementing Triplet Therapy in mHSPC - Christopher Pieczonka | |
/video-lectures/eau-2024/video... | Treating Metastatic Hormone-Sensitive Prostate Cancer: Beyond Counting Metastases - Karim Fizazi | |
/video-lectures/eau-2024/video... | Advancements in Cutting-Edge SABR Therapy for Oligometastatic Kidney Cancer - Shankar Siva | |
/video-lectures/psma-ucsf-ucla... | Patient Selection for Radioligand Therapy: Case Study Discussion - Amir Iravani & Evan Yu | |
/actionable-clinical-data/adst... | Implementing Nadofaragene Firadenovec Treatment in NMIBC - Mark Tyson, Aimee Boden, & Meghann Davis | |
/video-lectures/health-policy-... | Topical Estrogen Therapy in Preventing Recurrent UTIs in Women - Rachael Sussman, Charlotte Houston with Ruchika Talwar | |
/video-lectures/journal-club/v... | Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen | |
/video-lectures/bladder-cancer... | Sequential Gemcitabine and Docetaxel Shows Promise for Intermediate-Risk NMIBC - Vignesh Packiam | |
/video-lectures/non-muscle-inv... | Age Alone Should Not Preclude BCG Therapy in NMIBC - Ashish Kamat | |
/video-lectures/prostate-cance... | Novel Computational Approach Identifies NME2-MYC Axis as Biomarker and Therapeutic Target in Enzalutamide-Resistant CRPC - Antonina Mitrofanova | |
/video-lectures/asco-gu-2024/v... | Combining Pembrolizumab and BCG Immunotherapies: The KEYNOTE-676 Trial in High-Risk NMIBC - Neal Shore | |
/video-lectures/prostate-cance... | Advancing Personalized Medicine: Examining Trop2 as a Biomarker to Stratify Prostate Cancer Patient Risk - Tanya Stoyanova | |
/video-lectures/mcrpc-treatmen... | COMBAT Trial Yields Promising Results for Bipolar Androgen Therapy Plus Nivolumab in Metastatic Castration-Resistant Prostate Cancer - Mark Markowski & Emman... | |
/video-lectures/state-of-the-a... | The Use of Imaging in Staging Localized Prostate Cancer: A Case Study on High-Risk Localized Prostate Cancer - Zachary Klaassen | |
/actionable-clinical-data/adst... | Treatment Options Expand for BCG Unresponsive Bladder Cancer - Mark Tyson | |
/video-lectures/treatments-in-... | PIVOT-006 - A Study of Intravesical Cretostimogene Grenadenorepvec for Treatment of Patients with Intermediate-Risk, Non-Muscle Invasive Bladder Cancer - Mar... | |
/actionable-clinical-data/adst... | Establishing Nadofaragene Firadenovec in a Large Urology Practice - Daniel Canter | |
/actionable-clinical-data/adst... | Real-World Use of Nadofaragene Firadenovec - Siamak Daneshmand | |
/video-lectures/advanced-prost... | Patient Selection for PSMA Radioligand Therapy - Ephraim Parent | |
/video-lectures/psma-ucsf-ucla... | Access to Cutting-Edge Therapies and Clinical Trials in the VA- Matthew Rettig | |
/video-lectures/asco-gu-2024/v... | Predictive Markers in Metastatic Prostate Cancer: Insights from the VISION Trial - Oliver Sartor | |
/video-lectures/psma-targetedt... | Radioligand Therapy's Role in Treating mCRPC - Oliver Sartor | |
/video-lectures/psma-ucsf-ucla... | Highlights: UCLA/UCSF Inaugural PSMA PET and RLT Conference - Jeremie Calais | |
/video-lectures/advanced-prost... | Distinct Mesenchymal Cell States Mediate Prostate Cancer Progression - Massimo Loda | |
/video-lectures/health-policy-... | Access and Utilization of Healthcare by Adults with Spina Bifida - Lindsay Hampson & Alejandro Lopez | |
/video-lectures/health-policy-... | Comparing Cost-Effectiveness of Surgery, Radiation, and Chemo for Seminoma - Daniel Joyce | |
/video-lectures/testicular-can... | Testicular Cancer Survivors Find Community and Healing Through Foundation and Patient Summit - Connor O'Leary & Charles Freeman McCluskey | |
/video-lectures/advanced-prost... | Triple-Drug Therapies Usher in Sea Change for Men With High-Risk Prostate Cancer - Rashid Sayyid & Zachary Klaassen | |
/video-lectures/esmo-2023/vide... | Chinese Subgroup Analysis Reveals Both Similar and Distinct Responses to Novel Darolutamide Combination Therapy - Yao Zhu | |
/video-lectures/health-policy-... | Socioeconomic Disparities Drive Alarming Racial Gaps in Kidney Cancer Patient Survival Rates - Nirmish Singla | |
/video-lectures/the-prostate-c... | Novel Research Illuminates How CXCR7 Protein Interactions Promote Growth of Neuroendocrine Prostate Cancer - Jindan Yu | |
/video-lectures/prostate-cance... | How Chemotherapy Drives Metastasis By Causing Tumor Cells to Become Significantly More Mobile - Sarah Amend | |
/video-lectures/genomic-classi... | Deciphering Prostate Cancer: How Genomic Biomarkers are Shaping Treatment Decisions - Paul Nguyen | |
/video-lectures/pcf-2023/video... | Exploring the Multifaceted Role of a Medical Oncologist in Advanced Prostate Cancer Care and Management - Alicia Morgans | |
/video-lectures/mcrpc-treatmen... | Novel STEAP1 Targeted BiTE Therapy Demonstrates Early Efficacy in Phase 1 Trial - William Kevin Kelly | |
/video-lectures/precision-medi... | Genetic Testing Reveals Treatment Opportunity and Disparity in Advanced Prostate Cancer - Colin Pritchard | |
/video-lectures/pcf-2023/video... | INDICATE Trial Seeks to Clarify Role of PET Scans in Prostate Cancer Recurrence - Neha Vapiwala | |
/video-lectures/the-prostate-c... | The Complex Web of SPOP Mutations and STING1 Signaling in Prostate Cancer - Patrick Pilié | |
/video-lectures/esmo-2023/vide... | Innovative Prostate Cancer Therapy Insights Unveiled in ESMO 2023 Meeting - Alan Bryce | |
/video-lectures/esmo-2023/vide... | The LITESPARK-013 Trial and Belzutifan's Optimal Dose for Treating Metastatic Renal Cell Carcinoma - Neeraj Agarwal | |
/video-lectures/beyond-androge... | Real World Evidence Evaluating the Underutilization of Treatments for mCRPC in Clinical Practice - Mark Fleming | |
/video-lectures/beyond-androge... | Unlocking the Future of mCRPC Treatment: Exploring Immune Checkpoint Inhibitors for MMR Loss and MSI-High - Sumit Subudhi | |
/video-lectures/genomic-classi... | Correlation and Validation of Gene Expression Classifiers in Prostate Cancer: A Large-Scale Study - Daniel Spratt | |
/video-lectures/esmo-2023/vide... | PSMAfore Study Unveils Game-Changing Results for Prostate Cancer Treatment - Oliver Sartor | |
/video-lectures/health-policy-... | Prostate Cancer Drug Costs: A Complex Landscape of Out-of-Pocket Expenses - Benjamin Pockros | |
/video-lectures/health-policy-... | Innovation in Oncology Drug Pricing: A Comparative Study of Savings Potential - Ruchika Talwar & Brian Cortese | |
/video-lectures/bladder-cancer... | Probing the Promising Future of Anti-HER2 Therapies for Micropapillary Bladder Cancer - Jeffrey Ross | |
/video-lectures/asco-2023/vide... | A Breakthrough in Urothelial Cancer Treatment: Enfortumab Vedotin Combination Therapy - Expert Insights and Impressive Response Rates - Jonathan E. Rosenberg | |
/video-lectures/asco-2023/vide... | The Relationship Between a Priori Defined Prognostic Risk Groups and Overall Survival in Men with mCRPC - Susan Halabi | |
/video-lectures/advanced-bladd... | Radical Cystectomy Versus Trimodality Therapy for Muscle-Invasive Bladder Cancer: A Multi-Institutional Propensity Score Matched and Weighted Analysis - Jaso... | |
/video-lectures/patient-journe... | Choosing JELMYTO®: A Patient's Journey Through Less Invasive Upper Tract Urothelial Carcinoma Treatment - Tom Murphy | |
/video-lectures/asco-2023/vide... | Beyond BRCA-1 and 2: The Impact of the TALAPRO-2 Study on Prostate Cancer Care - Cora Sternberg | |
/video-lectures/asco-gu-2023/v... | Exploring Erdafitinib: A Breakthrough in Non-Muscle Invasive Bladder Cancer Treatment - Siamak Daneshmand | |
/video-lectures/women-in-scien... | Personal Passion Fuels Progress: Unraveling Prostate Cancer Aggressiveness in Black Men - Leanne Woods-Burnham | |
/video-lectures/non-muscle-inv... | Gene Therapy for NMIBC: A New Era of Treatment - Colin Dinney | |
/video-lectures/renal-cancer/v... | Enhancing Patient-Centered Communication in Small Renal Mass Management - Kathryn Hacker Gessner | |
/video-lectures/aua-2023/video... | Journal of Urology Open Plus - Revolutionizing Access and Innovation in Urology Research - John W. Davis | |
/video-lectures/aua-2023/video... | Improving Primary Prostate Cancer Diagnosis Through Risk Stratified Screening: a European Perspective - Sigrid Carlsson | |
/video-lectures/advanced-kidne... | Combining Belzutifan Plus Cabozantinib in Advanced Clear Cell Renal Cell Carcinoma, Exploring Novel Therapy Options - Toni Choueiri | |
/video-lectures/genomic-classi... | Risk Assessment in Localized Prostate Cancer - Insights from Real-World Data and SEER Registry - Jim Hu | |
/video-lectures/aua-2023/video... | Insights into the AUA Guidelines for Upper Tract Urothelial Carcinoma: Standardizing Diagnosis and Treatment for Better Patient Outcomes - Jonathan A. Coleman | |
/video-lectures/localized-pros... | ProtecT Trial Reveals New Insights for Prostate Cancer Treatment: Implications for Low-Risk vs. High-Risk Patients - David Penson | |
/video-lectures/aua-2023/video... | Assessing the Effectiveness of N-803 for BCG Unresponsive Bladder Cancer: Promising Complete Remission Rates and Improved Long-Term Response - Patrick Soon-S... | |
/video-lectures/the-prostate-c... | PSMA-Targeted Radioligand Therapy and Liquid Biopsy Characterizing PSMA Expression in Men with Metastatic Castration-Resistant Prostate Cancer - Andrew Armst... | |
/video-lectures/bladder-cancer... | Targeting the HLA-E/NKG2A Axis to Overcome BCG Resistance in NMIBC, BCAN Translational Clinical Trial Award - Amir Horowitz | |
/video-lectures/asco-gu-2023/v... | Safety and Disease Related Outcomes of mCRPC Patients Who Were Treated with Radium-223 Then 177Lu-PSMA (RALU) - Neal Shore | |
/video-lectures/asco-gu-2023/v... | Final Overall Survival Results from the PROpel Phase 3 Trial in First-line Therapy for mCRPC - Fred Saad | |
/video-lectures/women-in-scien... | The Role of Awareness and Support in Elevating Women in Science - Kristen Scarpato & Svetlana Avulova | |
/video-lectures/advanced-prost... | Biomarker Analysis to Identify Molecular Signatures Predictive of Response in the COMBAT Study - Emmanuel Antonarakis | |
/video-lectures/esmo-2022/vide... | Quality of Life and Patient-relevant Endpoints With Darolutamide in the ARASENS Trial - Karim Fizazi | |
/video-lectures/genomic-classi... | Insights from the STAMPEDE Trial Platform - Marina Parry & Gerhardt Attard | |
/video-lectures/apccc-2024/vid... | A Urologist's Perspective on PSMA-Radioligand Therapy in the Treatment Setting of mCRPC - Neal Shore | |
/video-lectures/asco-2022/vide... | CAR T and Cellular-Based Therapies - Vivek Narayan | |
/video-lectures/esmo-2022/vide... | The ARASENS Trial in Metastatic Hormone-Sensitive Prostate Cancer: Benefits In the Urologic Clinical Practice - Neal Shore | |
/video-lectures/ibcg-aua-2024-... | Timing of Radical Cystectomy in BCG Unresponsive Disease - Patrick Hensley | |
/video-lectures/aua-2022/video... | Women in Urologic Oncology - Anne K. Schuckman | |
/video-lectures/asco-2022/vide... | Multidisciplinary Care for Patients, a Book Interview - Alicia Morgans | |
/video-lectures/asco-2022/vide... | Multidisciplinary Care Teams to Optimize Care of Patients with Bone Metastatic CRPC - Tanya Dorff | |
/video-lectures/asco-2022/vide... | Clinical Trial Endpoints in the Adjuvant Setting for Renal Cell Carcinoma and Urothelial Cancer - Andrea Apolo and Pavlos Msaouel | |
/video-lectures/asco-2022/vide... | The Future of Radiopharmaceuticals in the Treatment of Prostate Cancer - Philip Kantoff | |
/video-lectures/aua-2022/video... | Bladder Cancer Highlights - Stephen Williams | |
/video-lectures/apccc-2024/vid... | APCCC 2022: First-Line Therapy for Metastatic Castration-Resistant Prostate Cancer - Evan Yu | |
/video-lectures/apccc-2024/vid... | Cancer Survivorship and PCF - Matthew Smith & Alicia Morgans | |
/video-lectures/esmo-2022/vide... | EV-103 Cohort K, Enfortumab Vedotin Monotherapy or in Combination With Pembrolizumab in Previously Untreated Cisplatin-Ineligible Patients With Locally Advan... | |
/video-lectures/esmo-2022/vide... | A Urologist's Perspective on the PROpel Trial, Olaparib and Abiraterone versus Abiraterone Alone, in the First-Line Metastatic Castration-Resistant Prostate ... | |
/video-lectures/genomic-classi... | An Ancillary Study of the STAMPEDE Trial Assessing the Clinical Qualification of Transcriptome Signatures for Advanced Prostate Cancer Starting ADT +/- Abira... | |
/center-of-excellence/imaging-... | Smarter Screening In Prostate Cancer - Sigrid Carlsson | |
/video-lectures/asco-2022/vide... | CheckMate 214: A Deep Dive into Ipilimumab and Nivolumab for Advanced Renal Cell Carcinoma - David Cella | |
/video-lectures/upper-tract-ur... | Evaluating the Impact of Variant Histology Pathologic Diagnosis on Survival Outcomes in Patients with Upper Tract Urothelial Carcinoma - Wesley Yip | |
/video-lectures/aua-2022/video... | Upper Tract Urothelial Carcinoma Highlights - Nima Almassi | |
/video-lectures/mhspc/video/me... | A Urologist's Perspective On Treatment with Darolutamide in the Metastatic Hormone Sensitive Patient - Neal Shore | |
/video-lectures/mhspc/video/me... | Outcomes of the ARASENS Trial by Metastatic Subtype - Bertrand Tombal | |
/video-lectures/mhspc/video/me... | Darolutamide Approved for Patients with mHSPC - Charles Ryan | |
/video-lectures/ibcg-aua-2024-... | The Role of Risk-Stratified Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer Who Are Undergoing Radical Cystectomy - Arlene O. Siefke... | |
/video-lectures/imaging-prosta... | First Standardized Framework Measuring PSMA PET/CT Response in Metastatic Castration‑Resistant Prostate Cancer - Wolfgang Fendler and Andrei Gafita | |
/video-lectures/advanced-prost... | The 6th Global Summit On Precision Diagnosis and Treatment Of Prostate Cancer - Faina Shtern, The AdMe Tech Foundation | |
/video-lectures/embark-trial/v... | The EMBARK Study: A Phase 3 Randomized Study of Enzalutamide Plus Leuprolide and Enzalutamide Monotherapy in High-Risk Nonmetastatic Hormone-Sensitive Prosta... | |
/video-lectures/practical-mana... | Optimizing the Use of Radium-223 Through Multidisciplinary Collaboration - Phillip Koo | |
/video-lectures/upper-tract-ur... | Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101 in the OLYMPUS Trial - John Gore | |
/video-lectures/bladder-cancer... | Management Trends & Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma, the USC Experience - Anirban Mitra | |
/video-lectures/upper-tract-ur... | Comparative Effectiveness of Neoadjuvant Chemotherapy In Bladder And Upper Urinary Tract Urothelial Carcinoma- Jeffrey Holzbeierlein | |
/video-lectures/upper-tract-ur... | Preventing Recurrence of Urothelial Carcinoma in Patients with Upper Tract Carcinoma - Aditya Bagrodia | |
/video-lectures/intermittent-c... | Convatec GentleCath™ Glide No-Touch Catheters - Diane Newman | |
/video-lectures/intermittent-c... | Uncoated Catheters - Diane Newman | |
/video-lectures/intermittent-c... | Closed Catheters Systems - Diane Newman | |
/video-lectures/crpc-w-bone-me... | Treatment Sequencing with Radium-223 in Symptomatic Disease - Fred Saad | |
/video-lectures/apccc-2024/vid... | Depression, Bone Health and Exercise in Prostate Cancer - Fred Saad, Tomasz Beer & Charles Ryan | |
/video-lectures/aua-2022/video... | Incorporating Genomic Testing for Prostate Cancer into Your Practice - Daniel Lin | |
/video-lectures/intermittent-c... | Self Intermittent Catheters Types - Diane Newman | |
/video-lectures/bladder-cancer... | Surveillance Guidelines for Low-Grade Ta NMIBC Often Not Followed - Stephen Williams | |
/video-lectures/psma-targetedt... | A Urologist's Perspective On the Integration of Lutetium Into Clinical Practices - Neal Shore | |
/video-lectures/aua-2022/video... | Mental Health and Impact on Patients with GU Malignancies - Zachary Klaassen | |
/video-lectures/aua-2022/video... | The Importance of Multidisciplinary Collaboration in Urology Clinics - Neal Shore | |
/video-lectures/apccc-2024/vid... | PARPi Combination Therapy Use in Clinical Practice - Ready for Prime-Time? - Maha Hussain and Fred Saad | |
/video-lectures/asco-gu-2022/v... | Identifying Unmet Needs in the Patient Journey in Prostate Cancer - Alicia Morgans | |
/video-lectures/13th-uro-oncol... | Future Perspectives in Prostate Imaging in Developing Countries - Ronaldo Hueb Baroni | |
/video-lectures/localized-pros... | Barriers and Opportunities in Active Surveillance, HIFU, and Focal Therapy in Latin American Countries - Laurence Klotz | |
/video-lectures/bladder-cancer... | Microbiome Research in Bladder Cancer - Laura Bukavina | |
/video-lectures/advanced-bladd... | Outcomes Between Patients With and Without Prior Intravesical BCG, Who Received Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma - Rafee Talukd... | |
/video-lectures/13th-uro-oncol... | The Management of High-Risk Localized Disease and Double Therapy in the mCRPC Setting - Andrey Soares | |
/video-lectures/prostate-cance... | Novel Approaches in the Management of High-Risk Prostate Cancer - Ray Manneh Kopp | |
/video-lectures/intermittent-c... | Evidence Supporting the Use of Urinary Catheters for Intermittent Catheterization - Diane Newman | |
/video-lectures/13th-uro-oncol... | Lessons Learned in the STAMPEDE Trial - Nicholas James | |
/video-lectures/disparities-so... | Treatment Delay Experiences Among Black and White Men with Prostate Cancer - Bhav Jain & Christopher Dee | |
/video-lectures/overactive-bla... | Mechanistic Pathway Through Which Saphenous Nerve Stimulation Can Modulate Bladder Function - Paul Yoo | |
/video-lectures/overactive-bla... | Developing A Novel Neuromodulation Therapy for Treating Overactive Bladder - Anne Agur | |
/video-lectures/imaging-prosta... | Radiotherapy Guided by PSMA PET Molecular Imaging - Juan Galvis Serrano | |
/video-lectures/practical-aspe... | Preparing for Treatment with 177Lu-PSMA-617 - Kendra Harris | |
/video-lectures/practical-aspe... | Administering Pluvicto™ - A Patient Shares His Treatment Experience of 177Lu-PSMA-617 - Kendra Harris and Phillip Koo | |
/center-of-excellence/imaging-... | Higher Rates of Metastatic Disease on PSMA PET for Biochemical Recurrence Risk Groups, Journal Club - Christopher Wallis & Zachary Klaassen | |
/video-lectures/genomic-classi... | The Performance of a Genomic Classifier Score in the Phase 3 SAKK 09/10 in Patients with Biochemical Progression - Alan Dal Pra | |
/video-lectures/advanced-prost... | Shared Decision-Making vs. Physician or Patient-Directed Decisions on Patient Quality of Life and Decision Satisfaction in Metastatic Prostate Cancer - Frank... | |
/video-lectures/bladder-cancer... | The Role of Bladder-Sparing Trimodality Therapy - Sophia Kamran | |
/video-lectures/bladder-cancer... | Biological Pathways in Urothelial Carcinoma - Carissa Chu | |
/video-lectures/upper-tract-ur... | Long-Term Safety and Durability to Non-Surgical Treatment Instillation of UGN-101, Mitomycin-Containing Reverse Thermal Gel for Low-Grade Upper Tract Urothel... | |
/video-lectures/bladder-cancer... | Treating Women with Bladder Cancer and a Community Approach to Navigating a Diagnosis - Jeannie Hoffman-Censits & Elizabeth Guancial | |
/video-lectures/advanced-kidne... | The Upcoming 2022 European International Kidney Cancer Symposium - Samra Turajlic | |
/video-lectures/asco-gu-2022/v... | Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients with High-Grade Upper Tract Urothelial Carcinoma - Wesley Yip | |
/video-lectures/practical-aspe... | Radiation Safety and the Integration of Pluvicto™ (177Lu-PSMA-617) in Treatment of mCRPC- Kendra Harris | |
/center-of-excellence/imaging-... | Clinical Trial Equity in Radionuclide Treatment for Prostate Cancer - Joseph Osborne | |
/video-lectures/psma-targetedt... | Clinical Implementation of Pluvicto™ (177Lu-PSMA-617) - Michael Morris | |
/video-lectures/apccc-2024/vid... | The APCCC 2022 - A Hybrid Meeting April 28 - 30 - Silke Gillessen | |
/video-lectures/asco-gu-2022/v... | Risk Stratification for Localized Prostate Cancer - Matthew Cooperberg | |
/video-lectures/asco-gu-2022/v... | Symptoms Related to Bone Metastasis in Men Receiving Lutetium-177 PSMA-617 for Prostate Cancer - Brian Gonzalez | |
/video-lectures/precision-medi... | Pluvicto The First Targeted Radioligand Therapy for Treatment of Metastatic Castration-Resistant Prostate Cancer FDA Approved - Charles Ryan and Alicia Morgans | |
/video-lectures/upper-tract-ur... | Molecular Biomarkers in Upper-Tract Urothelial Carcinoma - Janet Kukreja | |
/video-lectures/localized-pros... | Associations of Adverse Pathology With 20 Year Risk of Distant Metastasis and Prostate Cancer Specific Mortality - Michael Brooks | |
/video-lectures/asco-gu-2022/v... | The Effect of Durvalumab and Olaparib on Prolong Progression-Free Survival As First-Line Therapy in Platinum-Ineligible Patients With Unresectable Urothelial... | |
/video-lectures/asco-gu-2022/v... | Treatment and Survival Differences in Patients With Urothelial Vs. Nonurothelial Bladder & Upper Tract Carcinomas - Jeanny Aragon-Ching | |
/video-lectures/localized-pros... | Validating the Association of Adverse Pathology with Distant Metastasis and Prostate Cancer Mortality 20-Years After Radical Prostatectomy - Eric Klein | |
/video-lectures/asco-gu-2022/v... | The Next Wave of Novel Radiopharmaceuticals - Shahneen Sandhu | |
/video-lectures/psma-targetedt... | Appropriate Use Criteria for PSMA PET Imaging - Hossein Jadvar | |
/video-lectures/advanced-kidne... | KEYNOTE-564 30-Month Follow-Up of Pembrolizumab as Post Nephrectomy Adjuvant Therapy for Patients with Renal Cell Carcinoma - Toni Choueiri | |
/video-lectures/asco-gu-2022/v... | DS8201-a-U105 Trial of Trastuzumab Deruxtecan With Nivolumab in Patients With Urothelial Carcinoma – Matt Galsky | |
/video-lectures/genomic-classi... | Validation of Performance of the Decipher® Biopsy Genomic Classifier in Intermediate-Risk Prostate Cancer: The Phase III Randomized Trial NRG Oncology/RTOG 0... | |
/video-lectures/aua-2022/video... | Darolutamide and Survival in Metastatic Hormone-Sensitive Prostate Cancer - ARASENS Trial - Karim Fizazi | |
/video-lectures/imaging-prosta... | PSMA PET/CT Imaging Indications in Prostate Cancer - Neal Shore & Oliver Sartor | |
/video-lectures/bladder-cancer... | Research in Biomarkers for Bladder Cancer - The BCAN Young Investigator Awards - Benjamin Miron | |
/video-lectures/bladder-cancer... | Quality of Life for Patients Undergoing Radical Cystectomy - Bernard Bochner | |
/video-lectures/localized-pros... | Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer – Kara Maxwell | |
/video-lectures/bladder-cancer... | Perioperative Optimization for Patients Undergoing Radical Cystectomy – Sarah Psutka | |
/video-lectures/advanced-bladd... | Bladder Cancer Advocacy Network's (BCAN) Young Investigator Award Program - Elizabeth Plimack | |
/video-lectures/bladder-cancer... | Financial Toxicity Among Patients with Bladder Cancer - Deborah Kaye | |
/video-lectures/expert-voice/v... | From the Stage to the Clinic and Back: Medicine and Burnout - Stuart H. Bloom | |
/video-lectures/bladder-cancer... | Bladder Cancer: A Practical Guide - Ashish Kamat & Peter Black | |
/video-lectures/nccn-prostate-... | NCCN Guidelines 2022 - Prostate Cancer on Comparison of Treatment Options for Localized Disease + Local Therapies + Disease Monitoring - Zachary Klaassen and... | |
/video-lectures/non-muscle-inv... | Demonstrated Underuse of Blue Light Cystoscopy for Bladder Cancer in the United States - Patrick Lewicki | |
/video-lectures/crpc-w-bone-me... | Radium-223 Plus Enzalutamide versus Enzalutamide in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer - Neeraj Agarwal & Ben Maughan | |
/video-lectures/pcf-2021/video... | NCCN Guidelines On PSMA Molecular Imaging - Tanya Dorff | |
/video-lectures/crpc-w-bone-me... | A Real-World Analysis of Pain Efficacy of Radium-223 Treatment Among Patients With Metastatic Castration-Resistant Prostate Cancer and Symptomatic Bone Metas... | |
/video-lectures/mcrpc-treatmen... | Bispecific T-cell Engager (BiTE®) in Development for Treatment of Advanced Prostate Cancer - Oliver Sartor | |
/video-lectures/lugpa-2024/vid... | PSMA Imaging - Is Conventional Imaging Obsolete - Steven Rowe | |
/video-lectures/bladder-cancer... | Management of Small Local Recurrence Low-grade Bladder Tumors with Negative Cytology - Marek Babjuk, Morgan Roupret & Wassim Kassouf | |
/video-lectures/lugpa-2024/vid... | Urogynecology Controversies: Female Pelvic Medicine and Reconstructive Surgery - Briana Walton | |
/video-lectures/localized-pros... | Treatment-Related Regret Among Men With Localized Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen | |
/video-lectures/lugpa-2024/vid... | Theranostics - Taking Over Prostate Cancer Care? - Phillip H. Kuo | |
/video-lectures/psma-academy/v... | Understanding Physiological PSMA Biodistribution - Jeremie Calais | |
/video-lectures/pcf-2021/video... | Women in Science and The Prostate Cancer Foundation - Amina Zoubeidi | |
/video-lectures/mhspc/video/me... | Trials and Tribulations in the Management of Metastatic Hormone-Sensitive Prostate Cancer - Heather Payne | |
/video-lectures/bladder-cancer... | The World Bladder Cancer Patient Coalition Launches Bladder Cancer Patient Survey | |
/video-lectures/genomic-classi... | High Risk Prostate Cancer and Genomics - Paul Nguyen & Alan Pollack | |
/video-lectures/endourology-to... | Single-Use Disposable Cystoscopy - Roger Dmochowski, David Chaikin, & Vijay Goli | |
/video-lectures/esmo-2021/vide... | Cabazitaxel in Male Patients with Chemotherapy Pre-Treated Metastatic Germ-Cell Tumors CABA-GCT - Giulia Baciarello | |
/video-lectures/bladder-cancer... | Financial Toxicity in Bladder Cancer—A Mixed Methods Study of Two Diverse Patient Populations - Sumeet Bhanvadia | |
/video-lectures/crpc-w-bone-me... | Real-World Data in Second-Line Treatment Progressing mCRPC – Oliver Sartor | |
/video-lectures/advanced-prost... | Do Our Treatments Drive a New Resistant Mutational Phenotype? - Ana Aparicio | |
/video-lectures/upper-tract-ur... | Antegrade Endoscopic Upper Tract Approaches - Ryan Hsi | |
/video-lectures/esmo-2021/vide... | Time Course Profile of Adverse Events With Darolutamide in the ARAMIS Trial – Christian Gratzke | |
/video-lectures/upper-tract-ur... | Upper Tract Urothelial Carcinoma - Clinical Case Management in High-Risk Disease - Sima Porten | |
/video-lectures/esmo-2021/vide... | PSMAfore Trial - Evaluating 177Lu-PSMA-617 in Chemotherapy-Naïve mCRPC Patients – Michael Morris | |
/video-lectures/esmo-2021/vide... | Pain and Symptomatic Skeletal Events Reported in the VISION Trial – Oliver Sartor | |
/video-lectures/non-muscle-inv... | The Association of Smoking Status with Recurrence in Patients with Predominantly High-Risk Recurrent NMIBC - Richard Matulewicz | |
/video-lectures/nmcrpc/video/m... | Delayed Deterioration in Patient Quality of Life, the Impact of Darolutamide on Local Symptoms in the ARAMIS Trial – Neal Shore | |
/video-lectures/esmo-2021/vide... | STAMPEDE Analysis of Abiraterone With or Without Enzalutamide Added to Androgen Deprivation Therapy Compared to ADT Alone In High-Risk Non-Metastatic Prostat... | |
/video-lectures/lower-urinary-... | A Novel Sublingual Vaccine for Prevention of Recurrent Urinary Tract Infections in Women - J. Curtis Nickel | |
/video-lectures/esmo-2021/vide... | Overall Survival Results of PEACE-1 a Phase 3 Trial in Men With De Novo Metastatic Castration-Sensitive Prostate Cancer (mCSPC) – Karim Fizazi | |
/video-lectures/esmo-2021/vide... | Health-Related Quality of Life (HRQoL) From the Phase 3 VISION Study of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer – Kar... | |
/video-lectures/lower-urinary-... | The Effects of Vibegron on Ambulatory Blood Pressure in Patients With Overactive Bladder - Michael A. Weber | |
/video-lectures/bladder-cancer... | Choice of Urinary Diversion in Patients Undergoing Radical Cystectomy - Peter Black, Jens Bedke, and Hugh Mostafid | |
/video-lectures/asco-2021/vide... | Impact of Age on Castration Rates from The HERO Study – Michael Cookson | |
/video-lectures/upper-tract-ur... | Risk Stratification of Upper Tract Urothelial Carcinoma - Doug Scherr | |
/video-lectures/crpc-w-bone-me... | Real-World Safety and Effectiveness of Radium-223 in Japanese Patients with Castration-Resistant Prostate Cancer (CRPC) and Bone Metastasis - Beyond the Abst... | |
/video-lectures/practical-aspe... | The Stakeholders in Operationalizing an Integrated PSMA Imaging and Therapies Clinic - Kendra Harris | |
/video-lectures/localized-pros... | Personalized Hormone Therapy with Post-Operative Radiation Therapy and Validation of the Decipher® Genomic Classifier in SAKK 09/10 Trial - Dan Spratt and Al... | |
/video-lectures/localized-pros... | When to Add ADT to Early or Late Salvage Radiation - Dan Spratt | |
/video-lectures/localized-pros... | Clinical Case Discussions - "Rising PSA 18 Months Post RP and Timing of Radiotherapy" - Ashley Ross, Alan Dal Pra, and Dan Spratt | |
/video-lectures/snmmi-curricul... | Radium-223 Treatment for Metastatic Prostate Cancer - Ila Sethi | |
/video-lectures/advanced-bladd... | Implications for Genetic Testing in Urothelial Cancer - Guru Sonpavde & Maria Carlo | |
/video-lectures/mcrpc-treatmen... | The NCCN Guidelines on the Use of Radium-223 in Prostate Cancer - Tanya Dorff | |
/video-lectures/asco-2021/vide... | Health-Related Quality of Life Assessment for Patients With Advanced or Metastatic Renal Cell Carcinoma in the CLEAR Trial – Bradley McGregor | |
/video-lectures/psma-targetedt... | The Clinical Implications of The VISION Trial, PSMA-Targeted Radiotherapy in Metastatic Prostate Cancer - Michael Morris | |
/video-lectures/overactive-bla... | The OAB Clinical Care Pathway Mobile APP - Stephen Kraus | |
/video-lectures/upper-tract-ur... | Management and Challenges of Low Grade Upper Tract Urothelial Carcinoma - Surena Matin | |
/video-lectures/bladder-cancer... | The Clinical Impact and Molecular Drivers of ‘Secondary’ Muscle-Invasive Bladder Cancer - BCAN New Discoveries Young Investigator Award - Eugene J. Pietzak | |
/video-lectures/psma-targetedt... | Phenotypic Expression of Prostate Specific Membrane Antigen (PSMA) - Evan Yu | |
/video-lectures/localized-pros... | PCORI-Funded Initiative Evidence Gaps To Guide Future Research on the Use of Active Surveillance for Prostate Cancer – M. Minhaj Siddiqu | |
/video-lectures/bladder-cancer... | The Management of Primary Carcinoma of The Urethra - Reza Mehrazin | |
/video-lectures/journal-club/v... | 18F-DCFPyL PET/CT Imaging in Patients with Suspected Recurrence of Prostate Cancer (CONDOR) Journal Club - Christopher Wallis & Zachary Klaassen | |
/video-lectures/crpc-w-bone-me... | Optimal Patient Selection for Treatment with Radium-223 in mCRPC Towards Improved Overall Survival and Improved Quality of Life - Brenda Martone | |
/video-lectures/asco-2021/vide... | Defining the Standard of Therapy for First-Line mHSPC - Lisa Horvath | |
/video-lectures/bladder-cancer... | Sexual Function in Women Undergoing Radical Cystectomy, BCAN New Discoveries Young Investigator Award for Patient-Centered Research - Svetlana Avulova | |
/video-lectures/upper-tract-ur... | How I Use Jelmyto™ - Karim Chamie | |
/video-lectures/asco-2021/vide... | 177LuPSMA-617 - A New Standard of Care in the Treatment of mCRPC Based on The Phase III VISION Trial Results - Michael Morris | |
/video-lectures/journal-club/v... | A Systematic Review of the Effectiveness and Toxicities of Lutetium-177-labeled PSMA-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate... | |
/video-lectures/imaging-prosta... | PYLARIFY®, F 18-labeled PSMA Targeted PET Gains US FDA Approval - Michael Morris | |
/video-lectures/testicular-can... | Results From the IGCCCG Update Consortium in Metastatic Seminoma And Nonseminomatous Germ Cell Tumors – Silke Gillessen | |
/video-lectures/upper-tract-ur... | Upper Tract Urothelial Carcinoma - Clinical Case Management – Jonathan Coleman | |
/video-lectures/cardiovascular... | Assessment and Treatment of Cardiovascular Risk Factors in Veterans with Prostate Cancer - Ravi Parikh and Lova Sun | |
/video-lectures/non-muscle-inv... | The Use of Blue Light Cystoscopy for Both Hospital and Outpatient Clinic - Yair Lotan and Daniel Parker | |
/video-lectures/mcrpc-treatmen... | Real-World Evidence For Patients with mCRPC Treated with Cabazitaxel - Ronald de Wit | |
/video-lectures/mhspc/video/me... | Apalutamide Confirms Overall Survival Benefit at 44-Months in Metastatic Castration-Sensitive Prostate Cancer - The TITAN Study - Neeraj Agarwal | |
/video-lectures/testicular-can... | Survivorship in Testicular Cancer - Mary Dunn | |
/video-lectures/advanced-bladd... | Practical Considerations for Administering Avelumab Maintenance in Clinical Practice - Petros Grivas and Neeraj Agarwal | |
/video-lectures/asco-gu-2021-b... | Pembrolizumab in the Real-World Setting for Non-Muscle-Invasive Bladder Cancer Unresponsive to BCG - Arjun Balar | |
/video-lectures/non-muscle-inv... | Molecular Landscape of NMIBC and Risk Factors for Progression A Lecture & Discussion - Eugene Pietzak | |
/video-lectures/lower-urinary-... | Facing Pelvic Pain - Elise De | |
/video-lectures/asco-gu-2021-p... | Cabazitaxel is Active in Men with mCRPC with DDR Alterations - Karim Fizazi and Mihaela Aldea | |
/video-lectures/advanced-prost... | Patient Selection for ADT Treatment with the Oral GnRH Antagonist in Clinical Practice - Ashley Ross | |
/video-lectures/lower-urinary-... | The Role and Timing of Urodynamics and Certificate in Urodynamics Virtual Course - Hashim Hashim | |
/video-lectures/genomic-classi... | A Systematic Review of the Decipher® Genomic Classifier in Prostate Cancer - Ashley Ross & Daniel Spratt | |
/video-lectures/asco-gu-2021-p... | Sequential Radium-223 Treatment of mCRPC That Progressed After First-Line Novel Antihormonal Therapy, A Real-World Clinical Outcomes Study - Oliver Sartor | |
/video-lectures/mcrpc-treatmen... | Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer: COSMIC-021 - Neeraj Agarwal | |
/video-lectures/bladder-cancer... | Advances from 2020 in the Management of Muscle Invasive Non-Metastatic Bladder Cancer - Bernard Bochner | |
/video-lectures/endourology-to... | Surgical Simulator for Laparoscopic Partial Nephrectomy for Renal Cell Carcinoma - Gonzalo Vitagliano | |
/video-lectures/mcrpc-treatmen... | NCCN Guidelines Updated for Prostate Cancer M1 Systemic Therapy Based Upon The CARD Trial - Tanya Dorff | |
/video-lectures/imaging-prosta... | The Accidental Journey of Shepherding PSMA PET Imaging in Prostate Cancer to the Clinic in the United States - Thomas Hope | |
/video-lectures/prostate-cance... | Clinical Implications of the Study Findings from the Radiotherapy Adjuvant Versus Early Salvage ((TROG 08.03/ANZUP RAVES) Trial - Andrew Kneebone and Declan ... | |
/video-lectures/molecular-diag... | Operationalizing Genomic Testing for Clinical Practice In Prostate Cancer - Jason Hafron | |
/video-lectures/mcrpc-treatmen... | The Progress and Promise of Prostate Cancer Treatments in 2020 - Charles Ryan & Alicia Morgans | |
/video-lectures/non-muscle-inv... | Nadofaragene Firadenovec for BCG Unresponsive NMIBC - Girish Kulkarni | |
/video-lectures/imaging-prosta... | 68Ga-PSMA-11 Joins FDA-Approved Tools for Management of Prostate Cancer - Thomas Hope | |
/video-lectures/expert-voice/v... | Racial Differences in Genomic Profiling in Prostate Cancer - Brandon Mahal | |
/video-lectures/nmcrpc/video/m... | Overall Survival Data from the Global, Phase 3 ARAMIS Trial in Men with Non Metastatic Castration-Resistant Prostate Cancer (nmCRPC) - Karim Fizazi | |
/video-lectures/snmmi-curricul... | Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics Symposium - Rob Flavell | |
/video-lectures/advanced-bladd... | Implications for Reducing Disparities in Muscle-Invasive Bladder Cancer - Samuel Washington III | |
/video-lectures/mcrpc-treatmen... | Interim Results from AMG 160 a half-life extended (HLE), PSMA-targeted, bispecific T-cell engager (BiTE®) immune therapy for metastatic castration-resistant ... | |
/video-lectures/localized-pros... | An Expert Discussion on Gleason 6 (Grade Group 1) Prostate Cancer - Scott Eggener | |
/video-lectures/mcrpc-treatmen... | Treatment Considerations For Disease Progression After Combination Therapy in mCRPC - Alicia Morgans | |
/video-lectures/molecular-diag... | The Role of FoundationOne® Liquid CDx in mCRPC - Oliver Sartor | |
/video-lectures/advanced-bladd... | The Dynamic Advancements in Personalized Treatments for Metastatic Urothelial Cancer - Andrea Apolo | |
/video-lectures/precision-medi... | DNA Repair and PARP Inhibitor Therapy in Prostate Cancer - Veda Giri, Patrick Pilié, and Arpit Rao | |
/video-lectures/non-muscle-inv... | Results of the SUO CTC Phase III Nadofaragene Firadenovec Trial for BCG Unresponsive NMIBC - Colin Dinney | |
/video-lectures/precision-medi... | PSMA-directed Therapy - Scott Tagawa and Michael Morris | |
/video-lectures/advanced-bladd... | JAVELIN Bladder 100: Results of First-line Maintenance Therapy Plus Best Supportive Care Demonstrates Significant Prolonged OS in Advanced Urothelial Cancer ... | |
/video-lectures/mhspc/video/me... | Therapeutic Options for Patients with Metastatic Hormone-Sensitive Prostate Cancer - Evan Yu | |
/video-lectures/bladder-cancer... | Neoadjuvant Vs. Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma - Alison Birtle & Surena Matin | |
/video-lectures/bladder-cancer... | A Discussion on Implementing the Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer AUA/ASCO/ASTRO/SUO Guidelines - Sam Chang | |
/video-lectures/bladder-cancer... | Blue Light Cystoscopy with Cysview® & Adjuvant Perioperative Chemotherapy for Nonmuscle-Invasive Bladder Cancer - Sia Daneshmand & Trinity Bivalacqua | |
/video-lectures/bladder-cancer... | Improving and Optimizing Transurethral Resection of Bladder Tumor (TURBT) Outcomes - Hugh Mostafid | |
/video-lectures/patient-voice/... | In His Own Voice: His 15-Year Journey with Advanced Prostate Cancer - Steve Poggi | |
/video-lectures/bladder-cancer... | A Debate on The Management of BCG Unresponsive - Cystectomy Ineligible Bladder Cancer Patients: Pembrolizumab Vs. Nadofaragene Firadenovec - Arjun Balar & Pe... | |
/video-lectures/advanced-prost... | HERO Phase III Trial: Results Comparing Relugolix, an Oral GnRH Receptor Antagonist Vs. Leuprolide Acetate for Advanced Prostate Cancer - Neal Shore | |
/video-lectures/mcrpc-treatmen... | Rucaparib, A PARP Inhibitor For The Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Wassim Abida | |
/video-lectures/precision-medi... | Clinical Understanding of PARP Inhibitors in Prostate Cancer - Elena Castro, Wassim Abida, and Karen Knudsen | |
/video-lectures/mcrpc-treatmen... | IMbassador250: A Study of Atezolizumab in Combination with Enzalutamide in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Christopher Swe... | |
/video-lectures/bladder-cancer... | Implications of the Bacillus Calmette-Guérin (BCG) Shortage - Joshua Meeks | |
/video-lectures/mcrpc-treatmen... | Outcomes from The PROCEED Registry: Survival of African-American and Caucasian Men After Sipuleucel-T Immunotherapy - Oliver Sartor | |
/video-lectures/expert-voice/v... | In Pursuit of Patient-Centered Care - Karen Knudsen | |
/video-lectures/patient-voice/... | Making Your Treatment Decision - Prostate Cancer Patient Interview with Andy Schwartz | |
/video-lectures/crpc-w-bone-me... | Bone Health and Osteoclast Targeted Therapies in Advanced Prostate Cancer - Matthew Smith | |
/video-lectures/covid-19-and-g... | NCCN Localized Prostate Cancer Patient Treatment Considerations During the COVID-19 Pandemic - Edward M. Schaeffer | |
/video-lectures/covid-19-and-g... | NCCN Metastatic Castration-Resistant Prostate Cancer Patient Treatment Considerations During the COVID-19 Pandemic - Edward M. Schaeffer and Alicia Morgans | |
/video-lectures/nmcrpc/video/m... | Prolonging Overall Survival in Men with Non-metastatic Castration Resistant Prostate Cancer ARAMIS Trial - Neal Shore | |
/video-lectures/mcrpc-treatmen... | The ORIOLE Trial Results Discussed: Outcomes of Observation vs SABR for Oligometastatic Prostate Cancer - Phuoc T. Tran | |
/video-lectures/upper-tract-ur... | Moving the Field Forward, Upper Tract Urothelial Carcinoma, The POUT Study - Alison Birtle | |
/video-lectures/clinical-trial... | Implementing Prostate Cancer Working Group 3 Criteria in Clinical Trials- Michael Morris and Lawrence Schwartz | |
/video-lectures/mcrpc-treatmen... | CARD Study Demonstrates Cabazitaxel Improves Pain and Health-Related Quality of Life Analysis in Patients with mCRPC - Karim Fizazi | |
/video-lectures/bladder-cancer... | A New Era In Systemic Therapies, Pembrolizumab for High Risk Non-Muscle Invasive BCG-Refractory Patients - Arjun Balar | |
/video-lectures/psma-targetedt... | The VISION Trial: Radionuclide Therapy Plus Standard Therapy for Metastatic Castration Resistant Prostate Cancer - Oliver Sartor and Michael Morris | |
/video-lectures/advanced-kidne... | First-line Therapy Options for Metastatic Renal Cell Carcinoma - Tian Zhang | |
/center-of-excellence/imaging-... | A Study Evaluating Optimal Use of Radioactive Drugs for Prostate Cancer Therapy - Misha Beltran | |
/video-lectures/mcrpc-treatmen... | Prospective, Real-World Data Analysis Showed Additional Overall Survival Benefit with Sipuleucel-T in African American Patients – Oliver Sartor | |
/video-lectures/molecular-diag... | Genetic Counseling in Prostate Cancer - Brittany Szymaniak | |
/video-lectures/nmcrpc/video/m... | Darolutamide Treated Patients Maintained Quality of Life in ARAMIS Trial - Fred Saad | |
/video-lectures/expert-voice/v... | Clinical Trials: Another Treatment Option for Patients - Tom Farrington | |
/video-lectures/mcrpc-treatmen... | Radium-223 in Clinical Practice - Phillip J. Koo | |
/video-lectures/mhspc/video/me... | Treatment Approaches in Metastatic Hormone Sensitive Prostate Cancer (mHSPC)- Alicia Morgans | |
/video-lectures/upper-tract-ur... | Challenges in the Diagnosis and Treatment of UTUC - Peter Black | |
/video-lectures/imaging-prosta... | Theranostic Approaches for Advanced Prostate Cancer - Michael Hofman | |
/video-lectures/expert-voice/v... | Immunotherapy Across Genitourinary Malignancies - James Gulley | |
/video-lectures/advanced-prost... | Optimizing ADT in Prostate Cancer Patients - Tom Keane | |
/video-lectures/journal-club/v... | Blue Light Cystoscopy for Diagnosis of Bladder Cancer - A Journal Club Review by Badrinath Konety | |
/video-lectures/bladder-cancer... | High Grade Non-Muscle Invasive Bladder Cancer and BCG Refractory Patient - Josh Meeks | |
/video-lectures/advanced-kidne... | CARMENA: Practice Changing Strategies for Kidney Cancer | |
/video-lectures/advanced-prost... | Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer (mCRPC) for Black versus White Men-Susan Halabi | |
/video-lectures/advanced-bladd... | Updates on Health-Related Quality-of-Life (HRQoL) analyses in GU Oncology - Cora Sternberg | |
/video-lectures/lower-urinary-... | Nocturia in the Aging Patient, Assessment and Treatment- Susann Varano | |
/video-lectures/advanced-prost... | Genetic Evaluation and Counseling in Prostate Cancer Treatment - Interview with Heather Cheng | |
/video-lectures/crpc-w-bone-me... | The State of Nuclear Medicine in the Treatment of Prostate Cancer - Interview with Oliver Sartor | |
/video-lectures/bladder-cancer... | Update on Bladder Cancer, Current Trials and Treatments - Bishoy Faltas | |
/video-lectures/advanced-prost... | Dedication to Multidisciplinary Management of GU Oncology - Alex Kutikov | |
/video-lectures/advanced-prost... | Clinical Implications of the Abi Race Study: Interview with Dan George | |
/video-lectures/crpc-w-bone-me... | Imaging Modality and Recommendations Included in RADAR 3: Interview with Phillip Koo | |
/video-lectures/prostate-cance... | Personalization of Therapy to Optimize Outcomes for Men with Prostate Cancer - Interview with Felix Feng | |
/video-lectures/localized-pros... | The Men’s Eating and Living (MEAL) Study, Diet Intervention in Men on Active Surveillance for Prostate Cancer - Interview with J. Kellogg Parsons | |
/video-lectures/prostate-cance... | Geriatric Assessment of Men with Prostate Cancer - Alicia Morgans | |
/video-lectures/advanced-prost... | New Concepts in ADT- Thomas Keane | |
/video-lectures/bladder-cancer... | Advances in Bladder Cancer - Systemic Therapies Including Immunotherapy - Petros Grivas | |
/video-lectures/nmcrpc/video/m... | nmCRPC - Early Treatment Leading to Favorable Outcomes - Fred Saad. | |
/video-lectures/bladder-health... | Defining Bladder Health - Ariana Smith | |
/video-lectures/bladder-cancer... | A Revolutionizing Time in Immuno-Oncology for Bladder Cancer - Neal Shore | |
/video-lectures/nmcrpc/video/m... | Meeting an Unmet Need in the Nonmetastatic Castration Resistant Prostate Cancer Patient Population - Maha Hussain | |
/video-lectures/advanced-prost... | Neoadjuvant Therapy for Men with High Risk Disease Prior to Prostatectomy - Mary-Ellen Taplin | |
/video-lectures/aua-2025/video... | Treatment Intensification Strategies for High-Risk Prostate Cancer Patients - Aaron Berger | |
/video-lectures/asco-gu-2025/v... | Combining Genomic Classifier and Digital Pathology Artificial Intelligence in Prostate Cancer Risk Stratification - Daniel Spratt | |
/video-lectures/genomic-classi... | Precision Risk Assessment in Prostate Cancer: Growing Utility in NCCN Guidelines - Rashid Sayyid & Zachary Klaassen | |
/video-lectures/genomic-classi... | Texto duplicado | Deciphering Prostate Cancer: How Genomic Biomarkers are Shaping Treatment Decisions - Paul Nguyen |
/video-lectures/genomic-classi... | Texto duplicado | Correlation and Validation of Gene Expression Classifiers in Prostate Cancer: A Large-Scale Study - Daniel Spratt |
/video-lectures/genomic-classi... | Decipher® Scores and PSMA PET Imaging: A Correlative Study in High-Risk Prostate Cancer - Amar Kishan | |
/video-lectures/genomic-classi... | Integrating the Use of Prostate Genomic Classifiers into Clinical Practice - A Clinical Pathway Approach - Katie Murray and Anne Lizardi-Calvaresi | |
/video-lectures/genomic-classi... | Transcriptome-Based Prognostic and Predictive Biomarker Analysis - The DECIPHER® Genomic Classifier for Prostate Cancer - Ashley Ross | |
/video-lectures/genomic-classi... | Texto duplicado | Insights from the STAMPEDE Trial Platform - Marina Parry & Gerhardt Attard |
/video-lectures/genomic-classi... | The Molecular Biology of Prostate Cancer - Christopher Barbieri | |
/video-lectures/genomic-classi... | Texto duplicado | An Ancillary Study of the STAMPEDE Trial Assessing the Clinical Qualification of Transcriptome Signatures for Advanced Prostate Cancer Starting ADT +/- Abira... |
/video-lectures/genomic-classi... | The Use of the Decipher® Biopsy Test Prior to Prostatectomy - Ashley Ross | |
/video-lectures/genomic-classi... | Texto duplicado | High Risk Prostate Cancer and Genomics - Paul Nguyen & Alan Pollack |
/video-lectures/immunotherapy-... | Sasanlimab Combined with BCG for High-Risk Non-Muscle Invasive Bladder Cancer - Matthew Galsky | |
/video-lectures/high-risk-non-... | Texto duplicado | SunRISe-1 Trial Advances Bladder Cancer Treatment with TAR-200 - Michiel Van der Heijden |
/video-lectures/high-risk-non-... | Novel Therapies for Non-Muscle Invasive Bladder Cancer: Expert Review - Felix Guerrero-Ramos | |
/video-lectures/clinical-trial... | Immunotherapy Advancements in Bladder Cancer: Clinical Trials, Early Intervention, and Toxicity Management - Matt Galsky & Neal Shore | |
/video-lectures/treatments-in-... | Understanding BCG Unresponsive NMIBC: Patient Perspectives, Treatment Options, and Clinical Guidance - Gautam Jayram | |
/video-lectures/clinical-trial... | Understanding Risk Stratification in Non-Muscle Invasive Bladder Cancer: Applying AUA Guidelines in Clinical Practice - Neal Shore | |
/video-lectures/eau-2025/video... | Complete vs Partial TURBT for Muscle-Invasive Bladder Cancer Treatment - Fredrik Liedberg, Marco Moschini & Benjamin Pradere | |
/video-lectures/eau-2025/video... | Treatment Approaches for Node-Positive Locally Advanced Bladder Cancer - Shilpa Gupta & Felix Guerrero-Ramos | |
/video-lectures/advanced-bladd... | Node-Positive Bladder Cancer: Treatment, Biomarkers, and Surgical Considerations - Neema Navai | |
/video-lectures/advanced-bladd... | Texto duplicado | A Case-Based Discussion on First-Line EV + Pembrolizumab for Metastatic Urothelial Carcinoma - Neal Shore |
/video-lectures/asco-gu-2025/v... | NEO-BLAST Trial: Evaluating Bladder Preservation After Neoadjuvant Therapy in Bladder Cancer - Marie-Pier St-Laurent | |
/video-lectures/asco-gu-2025/v... | Circulating Tumor DNA as Prognostic Biomarker in Perioperative Management of Muscle Invasive Bladder Cancer - Nimira Alimohamed | |
/video-lectures/asco-gu-2025/v... | Safety of Combining Radiotherapy with Antibody Drug Conjugates in Advanced Urothelial Carcinoma - Neil Desai | |
/video-lectures/asco-gu-2025/v... | TROPION-PanTumor01 Trial for Advanced Bladder Cancer - Funda Meric-Bernstam | |
/video-lectures/asco-gu-2025/v... | Genomic Characterization of Young-Onset Bladder Cancer - Alina Basnet | |
/video-lectures/asco-gu-2025/v... | Texto duplicado | Real-World Safety Profiles of First-Line Therapies for Advanced Urothelial Carcinoma - Amanda Nizam |
/video-lectures/asco-gu-2025/v... | Phase II Trial Results of Disitamab Vedotin and Toripalimab Combination for Muscle-Invasive Bladder Cancer - Xinan Sheng | |
/video-lectures/asco-gu-2025/v... | ctDNA as a Prognostic Biomarker in Bladder Cancer Treatment Decisions - Nimira Alimohamed | |
/video-lectures/asco-gu-2025/v... | Avelumab’s Survival Impact in Diabetic vs Non-Diabetic Bladder Cancer Patients - Shilpa Gupta | |
/video-lectures/asco-gu-2025/v... | Texto duplicado | Adjuvant Nivolumab in High-Risk Muscle Invasive Bladder Cancer Analysis Shows Improved Outcomes for Patients: CheckMate 274 - Matthew Galsky |
/video-lectures/asco-gu-2025/v... | RETAIN-2 Study Shows Promise for Bladder Cancer Preservation - Pooja Ghatalia | |
/video-lectures/asco-gu-2025/v... | The NIAGARA Trial Highlights the Role of Durvalumab in Bladder Cancer Treatment - Matthew Galsky | |
/video-lectures/asco-gu-2025/v... | Enfortumab Vedotin and Pembrolizumab Demonstrate Durable Responses in Advanced Bladder Cancer - Thomas Powles | |
/video-lectures/advanced-bladd... | Enfortumab Vedotin and Pembrolizumab in Practice: A Case Study in Metastatic Urothelial Carcinoma - Brenda Martone | |
/video-lectures/advanced-bladd... | Adaptive Radiotherapy in Bladder Cancer: Phase II Results from the RAIDER II Trial - Robert Huddart | |
/video-lectures/advanced-bladd... | RETAIN Trial: Sparing Bladder Removal in Muscle-Invasive Bladder Cancer Patients - Daniel Geynisman | |
/video-lectures/suo-2024/video... | Adjuvant Systemic Therapies for Urothelial Carcinoma: Current Evidence and Future Directions - Jean Hoffman-Censits | |
/video-lectures/suo-2024/video... | Serial ctDNA Testing Identifies Bladder Cancer Patients Who May Avoid Adjuvant Therapy - Joaquim Bellmunt | |
/video-lectures/suo-2024/video... | Consolidative Local Therapy in Metastatic Bladder Cancer After Systemic Treatment Response - Fed Ghali | |
/video-lectures/suo-2024/video... | Perioperative Systemic Therapies for Muscle-Invasive Bladder Cancer - Jacqueline Brown | |
/video-lectures/advanced-bladd... | Real-World Effectiveness of Enfortumab Vedotin in Advanced Urothelial Carcinoma - Umang Swami | |
/video-lectures/esmo-2024/vide... | Futibatinib and Pembrolizumab in FGFR-Altered Urothelial Cancer - Vadim Koshkin | |
/video-lectures/suo-2024/video... | Advances in Muscle-Invasive Bladder Cancer: Systemic Therapies and Surgical Innovations - Jen-Jane Liu | |
/video-lectures/bcan-think-tan... | Lessons Learned from Other Cancers that Can be Applied to Bladder Cancer - Petros Grivas | |
/video-lectures/suo-2024/video... | Texto duplicado | Emerging Neoadjuvant Combinations for Muscle-Invasive Bladder Cancer - Mamta Parikh |
/video-lectures/suo-2024/video... | Texto duplicado | BCG Unresponsive Bladder Cancer in 2024 - Ashish Kamat |
/video-lectures/advanced-bladd... | Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs - Beyond the Abstract | |
/video-lectures/lugpa-2024/vid... | Five Things Urologists Need to Know About Bladder and Kidney Cancer in 2025 "Presentation" - Gautam Jayram | |
/video-lectures/advanced-bladd... | Study Finds Whole Pelvis Radiotherapy Superior to Bladder-Only in MIBC Treatment - Gautier Marcq | |
/video-lectures/esmo-2024/vide... | Innovative Therapies in GU Cancers: Promising Targets in Urothelial and Kidney Cancer - Jonathan Rosenberg | |
/video-lectures/advanced-bladd... | Quality of life after Trimodality Therapy - Kimberley Mak | |
/video-lectures/esmo-2024/vide... | Texto duplicado | 5-Year Survival Outcomes in Cisplatin-Ineligible Patients from EV-103 - Jonathan Rosenberg |
/video-lectures/esmo-2024/vide... | NIAGARA Trial Shows Durvalumab Plus Chemotherapy Improves Survival in Muscle-Invasive Bladder Cancer - Thomas Powles | |
/video-lectures/esmo-2024/vide... | Texto duplicado | Nectin-4 Expression Not Predictive of Response in Enfortumab Vedotin Therapy - Thomas Powles |
/video-lectures/bladder-cancer... | Addressing Cognitive Decline in Bladder Cancer Patients Through Prehab and Rehab - Sarah Psutka | |
/video-lectures/bcan-think-tan... | Bridging Evidence to Practice: Bladder Cancer Therapy Guidelines and Global Implementation - Andrea Apolo | |
/video-lectures/advanced-bladd... | Texto duplicado | SWOG Trial On Standard vs Extended Lymphadenectomy in Muscle Invasive Bladder Cancer - Seth Lerner |
/video-lectures/esmo-2024/vide... | EV-302 Trial Analysis Evaluating Nectin-4 in Urothelial Cancer - Thomas Powles | |
/video-lectures/esmo-2024/vide... | Texto duplicado | NIAGARA Trial: Chemo Plus Durvalumab Improves Survival in Muscle-Invasive Bladder Cancer - Thomas Powles |
/video-lectures/bladder-cancer... | Variant Histology Bladder Cancer Challenges and Future Directions - Syed Hussain | |
/video-lectures/bcan-think-tan... | Bladder Cancer Research Explores Fecal Transplants and Nutritional Strategies - Laura Bukavina | |
/video-lectures/esmo-2024/vide... | Highlights in Non-Prostate GU Oncology from ESMO 2024 - Ignacio Duran | |
/video-lectures/esmo-2024/vide... | Enfortumab Vedotin and Stereotactic Radiation Tested Before Surgery in Muscle-Invasive Bladder Cancer in STAR-EV Trial - Tian Zhang | |
/video-lectures/esmo-2024/vide... | Event-Free Survival as Surrogate Endpoint in Muscle Invasive Bladder Cancer Research - Cora Sternberg | |
/video-lectures/esmo-2024/vide... | Bladder Cancer Breakthroughs in SunRISe-1, AMBASSADOR, and VOLGA Trials - Maria De Santis | |
/video-lectures/esmo-2024/vide... | Texto duplicado | SunRISe-4 Trial Explores TAR-200 and Cetrelimab Combination for Bladder Cancer Treatment - Andrea Necchi |
/video-lectures/esmo-2024/vide... | Texto duplicado | Disitamab Vedotin: Promising HER2-Targeted Therapy for Urothelial Cancer - Matthew Galsky |
/video-lectures/esmo-2024/vide... | Texto duplicado | AMBASSADOR Trial: Extended Follow-up on Adjuvant Pembrolizumab in Bladder Cancer - Andrea Apolo |
/video-lectures/advanced-bladd... | Texto duplicado | EV-302 Trial Establishes Treatment Standard for Urothelial Carcinoma - Daniel Petrylak |
/video-lectures/bladder-cancer... | Texto duplicado | Trimodal Therapy in Urothelial vs Non-Urothelial Bladder Cancer - Mario de Angelis |
/video-lectures/asco-2024/vide... | The Best of ASCO 2024 in Advanced Bladder Cancer - Shilpa Gupta | |
/video-lectures/asco-2024/vide... | Small Cell Neuroendocrine Carcinoma of Urinary Tract: Relapse Factors & Treatment - Omar Alhalabi | |
/video-lectures/bladder-cancer... | Texto duplicado | dMMR and MSI-H in Urothelial Carcinoma: Prevalence and Treatment Implications - Elias Chandran |
/video-lectures/bladder-cancer... | Texto duplicado | Bladder-Sparing Chemoradiation for Localized Bladder Cancer: Addressing the Unmet Need - Brent Rose |
/video-lectures/asco-2024/vide... | EV-302 Subgroup Analysis: Improved Outcomes for Cisplatin-Ineligible Advanced Urothelial Cancer Patients - Michiel Van der Heijden | |
/video-lectures/advanced-bladd... | SunRISe-2 Trial: TAR-200 and Cetrelimab vs. Chemoradiotherapy for Muscle-Invasive Bladder Cancer - Stephen Williams | |
/video-lectures/advanced-bladd... | Texto duplicado | Antibody-Drug Conjugates in Advanced Urothelial Cancer: Current Landscape and Future Directions - Matthew Galsky & Neal Shore |
/video-lectures/non-muscle-inv... | Texto duplicado | Innovative Trials Highlight Progress in Treating Urothelial Carcinoma at AUA 2024 - Karim Chamie |
/video-lectures/aua-2024/video... | AUA 2024 Urothelial Carcinoma Highlights - Woodson Smelser | |
/video-lectures/advanced-bladd... | Pembrolizumab + Chemoradiation vs. Trimodality Therapy for Muscle-Invasive Bladder Cancer: The KEYNOTE-992 Trial - Neal Shore | |
/video-lectures/clinical-trial... | Texto duplicado | Immunotherapy Advancements in Bladder Cancer: Clinical Trials, Early Intervention, and Toxicity Management - Matt Galsky & Neal Shore |
/video-lectures/bladder-cancer... | Texto duplicado | Balancing Bladder Preservation with Effective Treatment in Cancer Care - Petros Grivas |
/video-lectures/ibcg-aua-2024-... | Texto duplicado | Treatment Options for Advanced Urothelial Cancer Post-EV-302 - Shilpa Gupta & Karima Oualla |
/video-lectures/advanced-bladd... | Stool Microbiome Signature Predicts Response to Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer - Filippo Pederzoli & Massimo Alfano | |
/video-lectures/advanced-bladd... | EV-302 Subgroup Analyses: Enfortumab Vedotin + Pembrolizumab Effective Across Patient Subsets in Metastatic Urothelial Cancer - Jonathan Rosenberg | |
/video-lectures/eau-2024/video... | Texto duplicado | Navigating the Shift to Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Cancer: Key Considerations for Clinicians - Cora Sternberg |
/video-lectures/advanced-bladd... | Texto duplicado | Preclinical Study Evaluates Enfortumab Vedotin and Sacituzumab Govitecan with Radiation for Bladder Cancer - Kent Mouw |
/video-lectures/advanced-bladd... | Texto duplicado | Genomic Tumor Correlates of Response to Trimodal Therapy for Muscle-Invasive Bladder Cancer - Sophia Kamran |
/video-lectures/journal-club/v... | Texto duplicado | Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen |
/video-lectures/advanced-bladd... | Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma - Arlene Siefker-Radtke | |
/video-lectures/asco-gu-2024/v... | EV-302: Enfortumab Vedotin + Pembrolizumab Outperforms Chemo in Untreated Advanced Urothelial Cancer - Michiel Simon Van der Heijden | |
/video-lectures/asco-gu-2024/v... | Adjuvant Pembrolizumab in Urothelial Carcinoma: AMBASSADOR Study Findings - Andrea Apolo | |
/video-lectures/asco-gu-2024/v... | Outcomes of Enfortumab Vedotin After Platinum and Avelumab in Bladder Cancer - Amanda Nizam | |
/video-lectures/asco-gu-2024/v... | Combination Maintenance Therapy for Advanced Bladder Cancer Explored in MAIN-CAV Study - Shilpa Gupta | |
/video-lectures/health-policy-... | Utilization of Neoadjuvant Chemo Before Cystectomy - Hiten Patel | |
/video-lectures/advanced-bladd... | International Panel Defines Endpoints and Control Arms for Trials in Locally Advanced and Metastatic Bladder Cancer, Journal Club - Rashid Sayyid & Zachary K... | |
/video-lectures/advanced-bladd... | Multi-Disciplinary Panel Defines Clinical Trial Framework for Muscle-Invasive Bladder Cancer, Journal Club - Rashid Sayyid & Zachary Klaassen | |
/video-lectures/esmo-2023/vide... | Gemcitabine, Cisplatin and Immunotherapy: A Promising Mix for Advanced Bladder Cancer - Guru Sonpavde & Matthew Galsky | |
/video-lectures/esmo-2023/vide... | Novel Antibody-Drug Conjugate Combination Yields High Response in Advanced Bladder Cancer - Guru Sonpavde & Bradley McGregor | |
/video-lectures/esmo-2023/vide... | For Bladder Cancer Patients, New Hope From Immunotherapy Innovations from ESMO 2023 - Petros Grivas | |
/video-lectures/esmo-2023/vide... | The EV-302 Study and the Implications for Metastatic Bladder Cancer Care - Cora Sternberg | |
/video-lectures/asco-2023/vide... | EV-103 Study Update: Impressive Four-Year Data on Enfortumab Vedotin and Pembrolizumab Combination in Urothelial Cancer - Shilpa Gupta | |
/video-lectures/asco-2023/vide... | Outcomes with Immune Checkpoint Inhibitors in Patients with MTAP Alterations in Advanced Urothelial Carcinoma - Rafee Talukder | |
/video-lectures/asco-2023/vide... | Texto duplicado | A Breakthrough in Urothelial Cancer Treatment: Enfortumab Vedotin Combination Therapy - Expert Insights and Impressive Response Rates - Jonathan E. Rosenberg |
/video-lectures/advanced-bladd... | Texto duplicado | Radical Cystectomy Versus Trimodality Therapy for Muscle-Invasive Bladder Cancer: A Multi-Institutional Propensity Score Matched and Weighted Analysis - Jaso... |
/video-lectures/advanced-bladd... | New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with Second-Line Immune Checkpoint Inhibitors - Beyond the Abstract | |
/video-lectures/san-raffaele-u... | The San Raffaele Urologic Oncology Retreat: Examples of ECOG-ACRIN Research Initiatives - Petros Grivas | |
/video-lectures/aua-2023/video... | The TAR-200 Device in Muscle-Invasive Bladder Cancer: Safety, Efficacy, and Future Prospects - Mark D. Tyson, II | |
/video-lectures/aua-2023/video... | Addressing Challenges in Bladder Cancer Surgery: Enhancing Patient Outcomes and Preparing for Recovery - Sarah Psutka | |
/video-lectures/aua-2023/video... | Full Data Analysis of the Biology and Performance of Pre- and Post-Pembrolizumab VI-RADS for Predicting Pathological Response in MIBC: Insights from a Compre... | |
/video-lectures/bladder-cancer... | Pros and Cons of Organ-Sparing Cystectomy in Bladder Cancer Patients: Balancing Oncologic and Functional Outcomes - Param Mariappan & Maria Carmen Mir | |
/video-lectures/asco-gu-2023/v... | Long-Term Results of the IMvigor130 Study: Atezolizumab with or without Chemotherapy in Metastatic Urothelial Cancer – Matthew Galsky | |
/video-lectures/asco-gu-2023/v... | Neoadjuvant Chemo-Immunotherapy Affect on Downstaging in Cisplatin-Eligible and Ineligible MIBC Patients Prior to Definitive Surgery, HCRN GU14-188: Phase Ib... | |
/video-lectures/asco-gu-2023/v... | Gemcitabine, Cisplatin, and Nivolumab with Selective Bladder Sparing in MIBC: Co-Primary Endpoint Analysis of HCRN GU 16-256 Phase II Trial - Matthew Galsky | |
/video-lectures/asco-gu-2023/v... | Exploring Genetic Biomarkers of Response to Enfortumab Vedotin in Advanced Urothelial Carcinoma: Analysis of UNITE Dataset - Tanya Jindal & Vadim Koshkin | |
/video-lectures/asco-gu-2023/v... | Assessing the Impact of Enfortumab Vedotin and Pembrolizumab on QoL and Symptom Management in Urothelial Carcinoma: EV-103 Cohort K Study Results - Matthew M... | |
/video-lectures/asco-gu-2023/v... | The Phase 1B NABUCCO Trial: The Use of Either High or Low-Dose Preoperative Ipilimumab plus Nivolumab in Patients with Stage III Urothelial Cancer – Michiel ... | |
/video-lectures/asco-gu-2023/v... | Extended Follow-Up Results of the CheckMate 274 Trial: Adjuvant Nivolumab for Resected Muscle-Invasive Urothelial Carcinoma - Matthew Galsky | |
/video-lectures/asco-gu-2023/v... | Long-Term Follow-up from the JAVELIN Bladder 100 Trial - Srikala Sridhar | |
/video-lectures/advanced-bladd... | The Association Between FGFR3 Alterations and Response to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma - Gopa Iyer | |
/video-lectures/esmo-2022/vide... | The Use of Biomarkers in the Adjuvant Setting to Understand the Effect of Nivolumab in the Checkmate 274 Study - Andrea Necchi | |
/video-lectures/asco-gu-2023/v... | Results from the Phase 1b/2 FIDES-02 Study: Derazantinib for Metastatic Bladder Cancer with Activating FGFR1/2/3 Genetic Aberrations - Andrea Necchi | |
/video-lectures/asco-gu-2023/v... | Extended Follow-Up Results CheckMate 274 Trial and Results of Pembrolizumab Monotherapy in BCG-Unresponsive HR NMIBC: Findings from Cohort B of the KEYNOTE-0... | |
/video-lectures/asco-gu-2023/v... | TROPHY-U-01 Cohort 3 Primary Analysis Sacituzumab Govitecan in Combination with Pembrolizumab in Patients with Metastatic Urothelial Cancer That Progressed a... | |
/video-lectures/asco-gu-2023/v... | The Future of Immune Checkpoint Inhibitors in the First-Line Treatment of Metastatic Urothelial Carcinoma - Andrea Apolo | |
/video-lectures/advanced-bladd... | The Role of Avelumab Switch Maintenance Immunotherapy in the Front-Line Space of Patients with Advanced Urothelial Cancer - Srikala Sridhar | |
/video-lectures/advanced-bladd... | From Dismal to Promising: Discoveries Transforming Treatment Options for Advanced Urothelial Carcinoma - Shilpa Gupta | |
/video-lectures/esmo-2022/vide... | Results of Cohort K of the EV-103 Trial EV Monotherapy or in Combination With Pembro in Previously Untreated Cisplatin-Ineligible Patients With Locally Advan... | |
/video-lectures/asco-2022/vide... | Long-Term Outcomes in EV-301, Enfortumab Vedotin Versus Chemotherapy in Patients With Previously Treated Advanced Urothelial Carcinoma - Jonathan Rosenberg | |
/video-lectures/journal-club/v... | EV-201 Enfortumab Vedotin After PD-1 or PD-L1 Inhibitors in Cisplatin-Ineligible Patients with Advanced Urothelial Carcinoma, Journal Club - Christopher Wall... | |
/video-lectures/esmo-2022/vide... | Texto duplicado | EV-103 Cohort K, Enfortumab Vedotin Monotherapy or in Combination With Pembrolizumab in Previously Untreated Cisplatin-Ineligible Patients With Locally Advan... |
/video-lectures/journal-club/v... | Molecular Subtyping and Neoadjuvant Chemotherapy in Bladder Cancer - Christopher Wallis & Zachary Klaassen | |
/video-lectures/journal-club/v... | Pembrolizumab Alone or Combined With Chemotherapy vs Chemotherapy As First-Line Therapy for Advanced Urothelial Carcinoma in the KEYNOTE-361 Trial Journal Cl... | |
/video-lectures/journal-club/v... | CheckMate 274 Trial of Adjuvant Nivolumab vs Placebo in Patients Who Underwent Radical Surgery for High-Risk Muscle-Invasive Urothelial Carcinoma, Journal Cl... | |
/video-lectures/ibcg-aua-2024-... | Texto duplicado | The Role of Risk-Stratified Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer Who Are Undergoing Radical Cystectomy - Arlene O. Siefke... |
/video-lectures/asco-2022/vide... | ATLANTIS Trial Explores Precision Medicine in Urothelial Carcinoma - Robert Jones | |
/video-lectures/asco-gu-2022/v... | Overall Response Rate After Immune-Checkpoint Inhibitor Initiation and Post-ICI PFS in Patients With Advanced Urothelial Carcinoma - Dimitrios Makrakis | |
/video-lectures/advanced-bladd... | Texto duplicado | Outcomes Between Patients With and Without Prior Intravesical BCG, Who Received Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma - Rafee Talukd... |
/video-lectures/advanced-bladd... | Navigating the Complex Landscape of Adjuvant Trials in Urothelial Carcinoma - Robert Dreicer | |
/video-lectures/advanced-bladd... | The Role of ctDNA in Metastatic Urothelial Cancer - Alexander Wyatt | |
/video-lectures/asco-gu-2022/v... | Antibody-Drug Conjugates in Advanced Urothelial Cancer: Clinical Perspective - Scott Tagawa | |
/video-lectures/asco-gu-2022/v... | Final Analysis of the ATLANTIS Rucaparib Arm - Simon Crabb | |
/video-lectures/advanced-bladd... | Practice Changing Publications in Urothelial Carcinoma - Deborah Kaye | |
/video-lectures/asco-gu-2022/v... | Treatment Strategies in Advanced Urothelial Carcinoma - Stephen Boorjian | |
/video-lectures/asco-gu-2022/v... | The Future of Adjuvant and Neoadjuvant Therapy for Patients with Muscle-Invasive Bladder Cancer - Tracy Rose | |
/video-lectures/asco-gu-2022/v... | The Efficacy and Safety of Lenvatinib in Combination with Pembrolizumab in the Treatment of Cisplatin-Ineligible Patients in Advanced Urothelial Carcinoma (L... | |
/video-lectures/asco-gu-2022/v... | Highlights In Urothelial Carcinoma at GU ASCO 2022 - Guru Sonpavde | |
/video-lectures/asco-gu-2022/v... | Sacituzumab Govitecan in Combination with Pembrolizumab in Metastatic Urothelial Cancer - Petros Grivas | |
/video-lectures/advanced-bladd... | Clinical Outcomes With Anti-PD(L)1 Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma – Dimitrios Makrakis | |
/video-lectures/advanced-bladd... | Texto duplicado | Bladder Cancer Advocacy Network's (BCAN) Young Investigator Award Program - Elizabeth Plimack |
/video-lectures/lugpa-2024/vid... | Biomarkers and Next Generation Sequencing in Advanced Bladder Cancer - Noah Hahn | |
/video-lectures/advanced-bladd... | Cisplatin-Related Immunomodulation and Efficacy with Atezolizumab + Cisplatin Versus Carboplatin-Based Chemotherapy in Metastatic Urothelial Cancer - Matthew... | |
/video-lectures/advanced-bladd... | Texto duplicado | Implications for Genetic Testing in Urothelial Cancer - Guru Sonpavde & Maria Carlo |
/video-lectures/journal-club/v... | Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma, Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors: TROPHY-U-01 ... | |
/video-lectures/asco-2021/vide... | Neoadjuvant Atezolizumab with Gemcitabine and Cisplatin in Patients with Muscle-Invasive Bladder Cancer - Samuel A. Funt | |
/video-lectures/asco-2021/vide... | Durability and Long Term Outcome of Enfortumab Vedotin + Pembrolizumab in the EV-103 Study in Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial ... | |
/video-lectures/advanced-bladd... | Beyond Clinical Trials: Real-World Success with Trimodality Therapy in Bladder Cancer - Sean Sachdev & Praneet Polineni | |
/video-lectures/asco-2021/vide... | Updated Results from EV-201 Cohort 2 - Enfortumab Vedotin Is A Potential Non-Platinum Option for Cisplatin-Ineligible Patients Following Anti-PD-1/L1 Treatme... | |
/video-lectures/advanced-bladd... | Advances in the Treatment of Metastatic Urothelial Cancer - Matthew Galsky | |
/video-lectures/advanced-bladd... | Breaking Down the TROPHY-U-01 Trial: How Sacituzumab Govitecan Earned FDA Approval for Advanced Bladder Cancer - Neeraj Agarwal & Petros Grivas | |
/video-lectures/advanced-bladd... | Intersection of Biology and Clinical Characteristics Towards Personalized Sequential Treatments for MIBC - Andrea Necchi and Ewan Gibb | |
/video-lectures/advanced-bladd... | The Role of Imaging in Neoadjuvant Immunotherapy in Muscle-Invasive Bladder Cancer: A Case Study of PURE-01 - Andrea Necchi & Laura Marandino | |
/video-lectures/advanced-bladd... | TROPHY-U-01 Results Lead to Accelerated Approval of Sacituzumab Govitecan (Trodelvy) for Pretreated Metastatic Urothelial Carcinoma - Scott Tagawa | |
/video-lectures/clinical-trial... | Chemoradiation in Urothelial Carcinoma: The Herculean Effort Behind the SWOG 1806 Trial - Petros Grivas | |
/video-lectures/clinical-trial... | Variant Histologies of Bladder Cancer - Petros Grivas | |
/video-lectures/advanced-bladd... | Texto duplicado | Practical Considerations for Administering Avelumab Maintenance in Clinical Practice - Petros Grivas and Neeraj Agarwal |
/video-lectures/advanced-bladd... | Voluntary Withdrawal In The US of Durvalumab and of Atezolizumab in Metastatic Urothelial Carcinoma - Petros Grivas | |
/video-lectures/advanced-bladd... | Operationalizing the Use of Avelumab in Clinical Practice, The Phase III JAVELIN Bladder 100 Trial - Brenda Martone | |
/video-lectures/advanced-bladd... | Characterization of The Genomic Landscape of Post-Neoadjuvant Chemotherapy in MIBC Patients- Andrew Lenis | |
/video-lectures/advanced-bladd... | Metastatic and Muscle-Invasive Bladder Cancer European Association of Urology (EAU) Guidelines - J. Alfred Witjes | |
/video-lectures/advanced-bladd... | Molecular Changes Associated with Treatment Response in Muscle-Invasive Bladder Cancer Patients Treated with Cisplatin-Based Chemotherapy - Lars Dyrskjøt | |
/video-lectures/advanced-bladd... | Two-year JAVELIN Solid Tumor Data Phase 1 Final Results - Andrea Apolo | |
/video-lectures/advanced-bladd... | Comparing Nab-Paclitaxel and Paclitaxel in Platinum-Refractory Bladder Cancer - Srikala Sridhar | |
/video-lectures/advanced-bladd... | Texto duplicado | Implications for Reducing Disparities in Muscle-Invasive Bladder Cancer - Samuel Washington III |
/video-lectures/advanced-bladd... | Guidelines for Advanced Urothelial Carcinoma in First-line Treatment for Patients Ineligible or Unfit for Cisplatin - Michiel S. Van der Heijden | |
/video-lectures/advanced-bladd... | Evaluating Treatments in Advanced Urothelial Carcinoma - Guru Sonpavde | |
/video-lectures/advanced-bladd... | Association Between Clinical Outcomes and Exploratory Biomarkers in the JAVELIN Bladder 100 Trial, Advanced Urothelial Carcinoma - Srikala Sridhar | |
/video-lectures/advanced-bladd... | ESMO 2020: The TROPHY-U-01 Study- Sacituzumab Govitecan for Advanced Urothelial Carcinoma - Petros Grivas | |
/video-lectures/advanced-bladd... | ESMO 2020: Combination Therapies in Locally Advanced or Metastatic Urothelial Carcinoma Bladder Cancer - Josh Meeks | |
/video-lectures/advanced-bladd... | Current Treatment Approaches in Advanced Urothelial Carcinoma - Shilpa Gupta | |
/video-lectures/advanced-bladd... | Texto duplicado | The Dynamic Advancements in Personalized Treatments for Metastatic Urothelial Cancer - Andrea Apolo |
/video-lectures/advanced-bladd... | Prolonging Overall Survival in Patients with Muscle-Invasive Bladder Cancer - Petros Grivas | |
/video-lectures/advanced-bladd... | Treatment Approach: Case Study in Aggressiveness Metastatic Urothelial Carcinoma - Makarand Khochikar | |
/video-lectures/advanced-bladd... | Advancements in Treatments for Metastatic Urothelial Carcinoma (mUC) - Petros Grivas | |
/video-lectures/advanced-bladd... | Texto duplicado | JAVELIN Bladder 100: Results of First-line Maintenance Therapy Plus Best Supportive Care Demonstrates Significant Prolonged OS in Advanced Urothelial Cancer ... |
/video-lectures/advanced-bladd... | Assessing the Potential Cost-Effectiveness of the Addition of Atezolizumab to First-Line Platinum Chemotherapy in Advanced Urothelial Carcinoma - Ali Khaki | |
/video-lectures/advanced-bladd... | Progress in Bladder Cancer Research - Bishoy Faltas | |
/video-lectures/advanced-bladd... | IMvigor010 Primary Analysis from a Phase III Randomized Study of Adjuvant Atezolizumab versus Observation in High-Risk Muscle-Invasive Urothelial Carcinoma -... | |
/video-lectures/advanced-bladd... | JAVELIN Bladder 100: Avelumab for Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma - Thomas Powles | |
/video-lectures/advanced-bladd... | Controversial and Complex Cases in Urothelial Cancer - Srikala Sridhar | |
/video-lectures/advanced-bladd... | The Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in MIBC - Andrea Necchi | |
/video-lectures/advanced-bladd... | The Landscape of Advanced Bladder Cancer: A Review of the Last 30-Years - Cora Sternberg | |
/video-lectures/advanced-bladd... | Enfortumab Vedotin for Advanced Urothelial Carcinoma - Jonathan Rosenberg | |
/video-lectures/advanced-bladd... | Updates on Bladder Cancer Clinical Trials ASCO GU 2020 - Matthew Galsky | |
/video-lectures/advanced-bladd... | Recent Advances in the Treatment of Metastatic Urothelial Cancer - Petros Grivas | |
/video-lectures/advanced-bladd... | Treatments in Development for Muscle-invasive Bladder Cancer - Min Yuen Teo | |
/video-lectures/advanced-bladd... | Advanced Bladder Cancer Clinic: Are you Ready? - Neal Shore | |
/video-lectures/advanced-bladd... | Immunotherapy and Chemotherapy Use in Patients with Metastatic Bladder Cancer - Ronac Mamtani and Ravi Parikh | |
/video-lectures/advanced-bladd... | Circulating Tumor DNA in Urothelial Cancer - Interview with Bishoy Faltas | |
/video-lectures/advanced-bladd... | Upper Tract Urothelial Carcinoma Has a Luminal-Papillary T-cell Depleted Contexture and Activated FGFR3 Signaling - Bishoy Faltas | |
/video-lectures/advanced-bladd... | Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer - Matt Galsky | |
/video-lectures/advanced-bladd... | Antibody Drug Conjugates for the Treatment of Metastatic Urothelial Carcinoma - Petros Grivas | |
/video-lectures/advanced-bladd... | Erdafitinib Treatment in Metastatic Urothelial Carcinoma - Petros Grivas | |
/video-lectures/advanced-bladd... | Biomarker Testing in Metastatic Urothelial Carcinoma - Petros Grivas | |
/video-lectures/advanced-bladd... | The Performance Status and Response to Immune Checkpoint Inhibition in Patients with Advanced Urothelial Carcinoma - Ali Khaki | |
/video-lectures/advanced-bladd... | Results from CALGB 90601 in Metastatic Urothelial Carcinoma - Jonathan Rosenberg | |
/video-lectures/advanced-bladd... | Novel New Approaches in the Neoadjuvant Disease Setting for Bladder Cancer - Petros Grivas | |
/video-lectures/advanced-bladd... | Urinary Diversion after Radical Cystectomy - Morgan Roupret | |
/video-lectures/advanced-bladd... | Assessing and Managing Toxicities with Immune Checkpoint Inhibitors - Brenda Martone | |
/video-lectures/advanced-bladd... | Erdafitinib in Bladder Cancer - Arjun Balar | |
/video-lectures/advanced-bladd... | Implications of Clinical Response Following Neoadjuvant Chemotherapy - Seth Lerner | |
/video-lectures/advanced-bladd... | Treating Advanced Bladder Cancer - Petros Grivas | |
/video-lectures/advanced-bladd... | Optimizing Treatment Outcomes in Muscle Invasive Bladder Cancer (MIBC) - Wassim Kassouf | |
/video-lectures/advanced-bladd... | Bladder Sparing Strategies for Urothelial Cancer - Jason Efstathiou | |
/video-lectures/advanced-bladd... | Neoadjuvant Treatment in Muscle Invasive Bladder Cancer- Andrea Necchi | |
/video-lectures/advanced-bladd... | Antibody-drug Conjugate (ADC) Sacituzumab Govitecan in Metastatic UroThelial Carcinoma - Scott Tagawa | |
/video-lectures/advanced-bladd... | Joshua J. Meeks on SWOG 1806 Study | |
/video-lectures/advanced-bladd... | Combination Approaches with Immune-Checkpoint Blockade in Bladder Cancer - Matthew Galsky | |
/video-lectures/advanced-bladd... | Immune Checkpoint Inhibitors Trials in Urothelial Cancer: Recent Updates and Future Outlook - Andrea Apolo | |
/video-lectures/advanced-bladd... | A Conversation on Immuno-Oncology in Bladder Cancer - Petros Grivas | |
/video-lectures/advanced-bladd... | Update on Immunotherapy Advances in Renal and Bladder Cancer - Cora Sternberg | |
/video-lectures/advanced-bladd... | Advances in Bladder Cancer Beyond Immunotherapy and Checkpoint Inhibitors - Evan Yu | |
/video-lectures/advanced-bladd... | Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials -Pedro Barata | |
/video-lectures/advanced-bladd... | Texto duplicado | Updates on Health-Related Quality-of-Life (HRQoL) analyses in GU Oncology - Cora Sternberg |
/video-lectures/advanced-bladd... | The State of Advanced Bladder Cancer - New Data from AACR 2018 - Interview with Arjun Balar | |
/video-lectures/integrating-17... | Integration of Lutetium-177 and the Value of Shared Decisions with Practice Stakeholders - Jeffrey Zemencik | |
/video-lectures/integrating-17... | Expanding the Nuclear Hot Lab to Accommodate Lutetium-177 - Lyanne Gomez | |
/video-lectures/integrating-17... | Finding the Right Patient for Lutetium-177 PSMA Treatment - Kara Cossis | |
/video-lectures/integrating-17... | Coordinating & Transitioning Patient Care for Patients Who Receive Lutetium-177 - Elizabeth Davis | |
/video-lectures/integrating-17... | A Urologist’s Multidisciplinary Approach to Clinical Management of the Patient Receiving Lutetium-177 - Benjamin Lowentritt | |
/video-lectures/integrating-17... | Radiation Safety Considerations for the Authorized User when Operationalizing Lutetium-177 in the Urology Clinic - Robert Brookland | |
/video-lectures/integrating-17... | Multidisciplinary Transitions in Care for Patients Receiving Lutetium-177 - Benjamin Lowentritt & Robert Brookland | |
/video-lectures/beyond-androge... | AKT Inhibitors – Targeting PI3K/AKT/MTOR Signaling Axis - Cora Sternberg | |
/video-lectures/beyond-androge... | Texto duplicado | Real World Evidence Evaluating the Underutilization of Treatments for mCRPC in Clinical Practice - Mark Fleming |
/video-lectures/beyond-androge... | Broadening Treatment Horizons with CDK4/6 Inhibitors from Breast to Prostate Cancer - Rana McKay | |
/video-lectures/beyond-androge... | Bone Health Management for Advanced Prostate Cancer - Fred Saad | |
/video-lectures/beyond-androge... | Tumor Heterogeneity Selective Pressure – Why We Need New Targets? - Oliver Sartor | |
/video-lectures/beyond-androge... | Unlocking Precision Care: Germline & Somatic Literacy in Prostate Cancer - Elisabeth Heath | |
/video-lectures/beyond-androge... | Texto duplicado | Unlocking the Future of mCRPC Treatment: Exploring Immune Checkpoint Inhibitors for MMR Loss and MSI-High - Sumit Subudhi |
/video-lectures/beyond-androge... | PARP Inhibitors: Targeting DNA Repair Pathways - Neal Shore | |
/video-lectures/beyond-androge... | The Biological Basis of Metastatic Prostate Cancer – The Unmet Medical Need for New Targets and Novel Treatment Pathways - Dan George | |
/video-lectures/beyond-androge... | The Critical Intersection of Androgen Receptor Pathways and Cell Cycle Regulation in Prostate Cancer Therapy - Rana McKay | |
/video-lectures/beyond-androge... | The Current Treatment Landscape in Metastatic Hormone-Sensitive Prostate Cancer - Andrew Armstrong | |
/video-lectures/beyond-androge... | PSMA PET as a Biomarker for Advanced Prostate Cancer - Oliver Sartor | |
/video-lectures/beyond-androge... | 2023 Key Learnings in mCRPC Treatments – Alicia Morgans | |
/video-lectures/beyond-androge... | Treatment Decision Making in mHSPC: The Medical Oncologist and Patient “What the Patient Needs to Know” About this Disease and Treatment Options? - Brenda Ma... | |
/video-lectures/beyond-androge... | Treatment Decision Making in mCRPC: The Urologist and Patient “What the Patient Needs to Know” About His Disease and Treatment Options? - Brenda Martone | |
/video-lectures/beyond-androge... | Multidisciplinary Approach in the Treatment of Metastatic Prostate Cancer - Robert Dreicer | |
/video-lectures/imaging-prosta... | Comparing PSMA Ligands for Prostate Cancer Imaging - Michael Hofman | |
/video-lectures/apccc-2024/vid... | Hypofractionation in Prostate Cancer Radiotherapy: Balancing Efficacy and Safety - Neha Vapiwala | |
/video-lectures/apccc-2024/vid... | Texto duplicado | Escalation Strategies for Suboptimal PSA Decline in mHSPC - Mary-Ellen Taplin |
/video-lectures/localized-pros... | Texto duplicado | Testosterone Recovery After ADT: Timing, Predictive Factors, and Clinical Implications - Pierre Blanchard |
/video-lectures/apccc-2024/vid... | Radiating the Primary Tumor in Metastatic Hormone-Sensitive Prostate Cancer - Sandy Srinivas | |
/video-lectures/apccc-2024/vid... | EMBARK Trial: Enzalutamide Monotherapy and Combination Therapy for High-Risk Biochemical Recurrence - Neal Shore | |
/video-lectures/advanced-prost... | Texto duplicado | Personalizing Salvage Radiation and Hormone Therapy for Biochemical Recurrence - Daniel Spratt |
/video-lectures/apccc-2024/vid... | Prognostic and Predictive Factors in Metastatic Hormone-Sensitive Prostate Cancer - Matthew Smith | |
/video-lectures/psma-targetedt... | Optimizing Lutetium-PSMA Dosing in High-Volume Disease and Special Situations - Louise Emmett | |
/video-lectures/mhspc/video/me... | Sequencing Therapies in mCRPC After Progression on Combination Treatment - Ian Davis | |
/video-lectures/apccc-2024/vid... | Texto duplicado | Managing Frail Patients with Metastatic Hormone-Sensitive Prostate Cancer - Maria De Santis |
/video-lectures/apccc-2024/vid... | Redefining Low-Volume Metastatic Prostate Cancer in the Era of PSMA PET Imaging - Oliver Sartor | |
/video-lectures/mhspc/video/me... | Optimal Imaging Standards for Metastatic Castration-Sensitive Prostate Cancer - Michael Morris | |
/video-lectures/apccc-2024/vid... | Texto duplicado | The Use of PARP Inhibitors in mCRPC with BRCA1/2 Alterations - Joaquin Mateo |
/video-lectures/apccc-2024/vid... | Bone Health in Advanced Prostate Cancer: Findings from the STAMPEDE Trial and Hospital Episode Statistics - Noel Clarke | |
/video-lectures/apccc-2024/vid... | APCCC 2024: Bridging Clinical Gaps in Prostate Cancer Care - Silke Gillessen | |
/video-lectures/apccc-2024/vid... | Highlighting APCCC 2024: An International Prostate Cancer Meeting - Silke Gillessen & Aurelius Omlin | |
/video-lectures/apccc-2024/vid... | Navigating the Future of Prostate Cancer Treatment and Global Access at APCCC 2024 - Silke Gillessen | |
/video-lectures/apccc-2024/vid... | PSMA PET Imaging Hot Topics - Neal Shore & Jason Efstathiou | |
/video-lectures/apccc-2024/vid... | Texto duplicado | A Urologist's Perspective on PSMA-Radioligand Therapy in the Treatment Setting of mCRPC - Neal Shore |
/video-lectures/apccc-2024/vid... | Lutetium-617 - Treatment Sequencing Considerations for Metastatic Castration-Resistant Prostate Cancer - Neal Shore | |
/video-lectures/apccc-2024/vid... | Texto duplicado | APCCC 2022: First-Line Therapy for Metastatic Castration-Resistant Prostate Cancer - Evan Yu |
/video-lectures/apccc-2024/vid... | Texto duplicado | Cancer Survivorship and PCF - Matthew Smith & Alicia Morgans |
/video-lectures/apccc-2024/vid... | Immune Checkpoint B7-H3 - APCCC 2022 - Emmanuel Antonarakis | |
/video-lectures/apccc-2024/vid... | Optimal Sequencing - Should It Include Radium Given Lutetium? - Joe O'Sullivan | |
/video-lectures/apccc-2024/vid... | Genomic and Clinical Markers in nmCRPC APCCC 2022 Presentation - Joaquin Mateo | |
/video-lectures/apccc-2024/vid... | From ADT to Triplet Therapy: Rethinking Treatment Paradigms in Metastatic Hormone Sensitive Prostate Cancer - Matthew Smith & Kim Chi | |
/video-lectures/apccc-2024/vid... | Emerging Therapies and Therapeutic Targets in Prostate Cancer - Mark Rubin | |
/video-lectures/apccc-2024/vid... | Ironman Registry: Pioneering Data Collection and Biomarker Analysis in Prostate Cancer Research Daniel George | |
/video-lectures/apccc-2024/vid... | How Can Treatment Be Individualized By Using Genomic Classifiers? APCCC 2022 Presentation - Felix Feng | |
/video-lectures/apccc-2024/vid... | Who Needs Early Salvage Radiotherapy and Who Needs Adjuvant Radiotherapy in 2022? - Kosj Yamoah | |
/video-lectures/apccc-2024/vid... | Incorporating Molecular Testing into Clinical Practice for Prostate Cancer - Elena Castro & Colin Pritchard | |
/video-lectures/apccc-2024/vid... | Texto duplicado | Depression, Bone Health and Exercise in Prostate Cancer - Fred Saad, Tomasz Beer & Charles Ryan |
/video-lectures/apccc-2024/vid... | De-escalation Treatment Strategies in Metastatic Hormone-Sensitive Prostate Cancer - Bertrand Tombal | |
/video-lectures/apccc-2024/vid... | When Low-Volume on Conventional Imaging Goes Into High-Volume on Next-Generation Imaging in mHSPC - Karim Fizazi | |
/video-lectures/apccc-2024/vid... | The Use of PARP Inhibitors in Castrate-Resistant Prostate Cancer - Elena Castro & Joaquin Mateo | |
/video-lectures/apccc-2024/vid... | Texto duplicado | PARPi Combination Therapy Use in Clinical Practice - Ready for Prime-Time? - Maha Hussain and Fred Saad |
/video-lectures/apccc-2024/vid... | Closing Remarks from the 2022 Advanced Prostate Cancer Consensus Conference (APCCC 2022) - Silke Gillessen, Aurelius Omlin, Neal Shore, Charles Ryan & Alicia... | |
/video-lectures/apccc-2024/vid... | Systemic Treatment in the Context of Salvage Radiation and Biochemical Recurrence - Piet Ost | |
/video-lectures/genomic-classi... | The Conundrum of Systemic Salvage Therapy at the Time of Salvage Radiation Therapy - Brandon Mahal | |
/video-lectures/apccc-2024/vid... | Demystifying PSMA Theranostics: A Discussion on Implementing Lutetium-177 Treatment - Oliver Sartor | |
/video-lectures/apccc-2024/vid... | Beyond Clinical Trials: Mastering Patient Care for Lutetium-PSMA-617 Therapy - Michael Morris | |
/video-lectures/apccc-2024/vid... | Looking Forward to the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 - Aurelius Omlin | |
/video-lectures/apccc-2024/vid... | Texto duplicado | The APCCC 2022 - A Hybrid Meeting April 28 - 30 - Silke Gillessen |
/video-lectures/apccc-2024/vid... | The APCCC 2021 Focuses on Key Areas of Advanced Prostate Cancer Management: Newly Diagnosed mHSPC, PSMA in Diagnostics and Therapy and Novel Targets in mCRPC... | |
/video-lectures/apccc-2024/vid... | Looking Forward to The Advanced Prostate Cancer Consensus Conference (APCCC) 2021 - Silke Gillessen and Aurelius Omlin | |
/video-lectures/apccc-2024/vid... | Reflections on Advanced Prostate Cancer Consensus Conference 2019 - Srikala Sridhar | |
/video-lectures/apccc-2024/vid... | The Side Effects of Advanced Prostate Cancer Consensus Conference 2019 (APCCC) - Silke Gillessen and Aurelius Omlin | |
/video-lectures/aua-2025/video... | Texto duplicado | Real-World Data Improves NMIBC Risk Assessment with Blue Light Technology - Siamak Daneshmand & Boris Gershman |
/video-lectures/aua-2025/video... | Texto duplicado | Platform Reduces Unnecessary Cystoscopies for Hematuria Patients - John Sfakianos |
/video-lectures/non-muscle-inv... | Recombinant BCG Access Program Addresses US Bladder Cancer Shortage - Neal Shore | |
/video-lectures/immunotherapy-... | Texto duplicado | Sasanlimab Combined with BCG for High-Risk Non-Muscle Invasive Bladder Cancer - Matthew Galsky |
/video-lectures/aua-2025/video... | Texto duplicado | ARANOTE Study Shows Benefits of Deep PSA Response with Darolutamide - Neal Shore |
/video-lectures/aua-2025/video... | Cost-Effectiveness of 89Zr-DFO-Girentuximab PET Scan for Small Renal Mass Diagnosis - Pratik Kanabur | |
/video-lectures/asco-gu-2025/v... | Nadofaragene Firadenovec for BCG-Unresponsive Bladder Cancer: Efficacy, Logistics, and Real-World Implementation - Fed Ghali | |
/video-lectures/non-muscle-inv... | Papillary Non-Muscle Invasive Bladder Cancer Treatment Guidelines Gap - Patrick Soon-Shiong | |
/video-lectures/mcrpc-treatmen... | Health-Related Quality Outcomes for Pre-Chemotherapy mCRPC Treatment - Neal Shore | |
/video-lectures/mhspc/video/me... | Evolution of Treatment Approaches for Metastatic Hormone-Sensitive Prostate Cancer - Pedro Barata | |
/video-lectures/aua-2025/video... | Recombinant BCG Addressing Bladder Cancer Treatment Shortages - Patrick Soon-Shiong | |
/video-lectures/aua-2025/video... | CORE-008 Trial Cohort CX: Combining Cretostimogene Grenadenorepvec and Gemcitabine for Bladder Cancer - Trinity Bivalacqua | |
/video-lectures/mhspc/video/me... | Optimizing Multidisciplinary Care for Metastatic Hormone-Sensitive Prostate Cancer - Zachary Klaassen | |
/actionable-clinical-data/adst... | Reducing Treatment Burden in BCG-Unresponsive NMIBC: A Patient-Centered Approach - Sarah Psutka | |
/actionable-clinical-data/adst... | Real-World Experience With Nadofaragene Firadenovec Treatment for BCG-Unresponsive Bladder Cancer - Mark Tyson & Max Kates | |
/video-lectures/treatments-in-... | Cretostimogene Grenadenorepvec Investigated for BCG-Exposed High-Risk Bladder Cancer in CORE-008 - Trinity Bivalacqua | |
/video-lectures/aua-2025/video... | Management Strategies for Low-Grade Intermediate-Risk Bladder Cancer - Sarah Psutka | |
/video-lectures/aua-2025/video... | BOND-003 Cohort P Results for BCG-Unresponsive Papillary Bladder Tumors - Mark Tyson | |
/video-lectures/aua-2025/video... | CORE-008 Trial Explores Cretostimogene Grenadenorepvec for Multiple Bladder Cancer Patient Groups - Trinity Bivalacqua | |
/video-lectures/aua-2025/video... | Texto duplicado | Treatment Intensification Strategies for High-Risk Prostate Cancer Patients - Aaron Berger |
/video-lectures/treatments-in-... | BOND-003 Cohort C Trial Results for Cretostimogene Grenadenorepvec in BCG-Unresponsive Bladder Cancer - Mark Tyson | |
/video-lectures/embark-trial/v... | Texto duplicado | EMBARK Trial: Treatment Options for High-Risk Biochemical Recurrence - Neal Shore |
/video-lectures/embark-trial/v... | Comparing EMBARK vs EAU High-Risk Biochemical Recurrence Criteria in Prostate Cancer - Ugo Falagario | |
/video-lectures/asco-gu-2025/v... | EMBARK Trial Subanalysis for High-Risk Biochemical Recurrent Prostate Cancer - Stephen Freedland | |
/video-lectures/esmo-2024/vide... | Texto duplicado | EMBARK Trial: Age-Stratified Analysis of Enzalutamide in High-Risk Biochemically Recurrent Prostate Cancer - Neal Shore |
/video-lectures/embark-trial/v... | Discussion Between Expert Clinicians and Patients on the EMBARK Trial, A Journal Club for Patients with Prostate Cancer - Matthew Cooperberg | |
/video-lectures/embark-trial/v... | EMBARK Trial: Enzalutamide Monotherapy & Combination Therapy for High-Risk Prostate Cancer - Stephen Freedland, Neal Shore, & Rana McKay | |
/video-lectures/apccc-2024/vid... | Texto duplicado | EMBARK Trial: Enzalutamide Monotherapy and Combination Therapy for High-Risk Biochemical Recurrence - Neal Shore |
/video-lectures/embark-trial/v... | Texto duplicado | The Impact of the EMBARK Trial on Treatment Decisions in High-Risk Biochemical Recurrent Prostate Cancer - Neal Shore |
/video-lectures/embark-trial/v... | Advancing Prostate Cancer Care: The EMBARK Study and Implications for Clinical Practice - Stephen Freedland | |
/video-lectures/prostate-cance... | Novel Hormone Therapy and Coordination of Care in High-Risk Biochemically Recurrent Prostate Cancer - Beyond the Abstract | |
/video-lectures/embark-trial/v... | Parsing the Evidence from the EMBARK Trial on a Promising New Drug Regimen in High-Risk Non-Metastatic Hormone-Sensitive Prostate Cancer - Matthew Cooperberg | |
/video-lectures/embark-trial/v... | Interpreting EMBARK Trial Results: Intensified Treatment and Hormone Therapy in High-Risk Patients - Christian Gratzke | |
/video-lectures/embark-trial/v... | EMBARK Trial Shows Promising Results for High-Risk Prostate Cancer Treatment, Enzalutamide's Impact on Metastasis-Free Survival - Neal Shore | |
/video-lectures/embark-trial/v... | Texto duplicado | The EMBARK Study: A Phase 3 Randomized Study of Enzalutamide Plus Leuprolide and Enzalutamide Monotherapy in High-Risk Nonmetastatic Hormone-Sensitive Prosta... |
/conference-highlights/aua-202... | Sin texto | |
/conference-highlights/aua-202... | AUA 2025: A Novel Core Needle Biopsy Instrument Designed for Targeted Biopsy | |
/conference-highlights/aua-202... | New Patient-Reported Outcomes from UGN-102 Clinical Trials Show the Investigational Treatment Did Not Adversely Affect Functionality, Symptom Burden, and Qua... | |
/conference-highlights/aua-202... | AUA 2025: Impact of Prior Holmium Laser Enucleation of the Prostate (HoLEP) on the Accuracy of PI-RADS for Assessing Clinically Significant Prostate Cancer | |
/conference-highlights/aua-202... | View all AUA 2025 coverage | |
/conference-highlights/ses-aua... | Sin texto | |
/conference-highlights/ses-aua... | SES AUA 2025: Artificial Intelligence Applications in Prostate Cancer Diagnosis and Treatment | |
/conference-highlights/ses-aua... | SES AUA 2025: Overall Survival with Darolutamide Versus Placebo in Combination with Androgen Deprivation Therapy and Docetaxel Accounting for Subsequent Ther... | |
/conference-highlights/ses-aua... | SES AUA 2025: Early Longitudinal Outcomes of Black Men Undergoing PSA Screening Following Implementation of a PSA-Based Risk Stratification Algorithm in a He... | |
/conference-highlights/ses-aua... | View all SES AUA 2025 coverage | |
/library-resources/advanced-bl... | The Quickly Evolving Treatment Landscape of Metastatic Urothelial Carcinoma: A New Standard of Care in First-Line Systemic Therapy | |
/library-resources/advanced-bl... | The Treatment Landscape of Metastatic Urothelial Carcinoma: Second-Line Systemic Therapy | |
/center-of-excellence/advanced... | View all Advanced Bladder Cancer | |
/library-resources/m0-prostate... | Beyond a VISION to Making a SPLASH: Advances in PSMA-Based Theranostics in Prostate Cancer | |
/center-of-excellence/psma-tar... | View all PSMA-Targeted Therapy | |
/conference-highlights/aua-202... | AUA 2025: Ultra-low PSA Response (0.02 ng/mL) with Darolutamide Plus ADT in ARANOTE Correlates with Greatly Improved Clinical Outcomes | |
/conference-highlights/aua-202... | Texto ancla no relevante Read More | |
/conference-highlights/aua-202... | AUA 2025: An Update on QUILT-3.032: Complete Responses to N-803 plus BCG Therapy in BCG-Unresponsive Bladder Carcinoma In Situ (CIS) with or without Ta/T1 Pa... | |
/conference-highlights/aua-202... | Texto duplicado | Texto ancla no relevante Read More |
/conference-highlights/aua-202... | CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the A... | |
/conference-highlights/aua-202... | Texto duplicado | Texto ancla no relevante Read More |
/conference-highlights/asco-gu... | ASCO GU 2025: Darolutamide Monotherapy in Patients with CSPC after Biochemical Recurrence: ARAMON Lead-in Phase Results | |
/conference-highlights/asco-gu... | Texto duplicado | Texto ancla no relevante Read More |
/about-urotoday.html | About UroToday | |
/heading-journal.html | Journals | |
/calendar.html | Calendar | |
/editorial-and-advertising-gui... | Editorial and Advertising Guidelines | |
/editorial-leadership.html | Editors and Contributors | |
/frequently-asked-questions-fa... | FAQs | |
/privacy-policy.html | Texto duplicado | Privacy Policy |
/terms-of-use.html | Terms of Use | |
https://www.facebook.com/UroTo... | Externo Subdominio | Sin texto |
https://twitter.com/urotoday | Externo | Sin texto |
https://www.linkedin.com/compa... | Externo Subdominio | Sin texto |
/my-profile/lostpassword.html | Forgot Password? | |
/register.html | Texto duplicado | Sign Up Free |
Nombre | Valor |
---|---|
date | Tue, 13 May 2025 05:03:34 GMT |
content-type | text/html; charset=utf-8 |
p3p | CP="NOI ADM DEV PSAi COM NAV OUR OTRo STP IND DEM", CP="NOI ADM DEV PSAi COM NAV OUR OTRo STP IND DEM" |
expires | Wed, 17 Aug 2005 00:00:00 GMT |
pragma | no-cache |
cache-control | no-store, no-cache, must-revalidate, post-check=0, pre-check=0, no-cache |
set-cookie | 91 Caracteres |
last-modified | Tue, 13 May 2025 05:01:58 GMT |
etag | "a1f6001601f59c18fb9aa100dfaa0070-gzip" |
vary | Accept-Encoding |
content-encoding | gzip |
x-content-type-options | nosniff |
cf-cache-status | DYNAMIC |
server | cloudflare |
cf-ray | 93ef9c2d5f323772-CDG |
alt-svc | h3=":443"; ma=86400 |
statuscode | 200 |
http_version | HTTP/2 |
# If the Joomla site is installed within a folder such as at # e.g. www.example.com/joomla/ the robots.txt file MUST be # moved to the site root at e.g. www.example.com/robots.txt # AND the joomla folder name MUST be prefixed to the disallowed # path, e.g. the Disallow rule for the /administrator/ folder # MUST be changed to read Disallow: /joomla/administrator/ # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/orig.html # # For syntax checking, see: # http://www.sxw.org.uk/computing/robots/check.html User-agent: * crawl-delay: 10 Allow: /*.js* Allow: /*.css* Allow: /*.png* Allow: /*.jpg* Allow: /*.gif* Disallow: /SimpleSignOn.modal Disallow: /*.raw$ User-agent: Googlebot User-agent: Googlebot-News crawl-delay: 10 Disallow: /categories/1956-video-transcripts*.html Disallow: /uij-archives/1956-video-transcripts*.html Disallow: /component/content/category/1956-video-transcripts Disallow: /*/1228-conferences*.html Disallow: /*/1964-library-resources*.html Disallow: /administrator/ Disallow: /cache/ Disallow: /cli/ # Don't want to index these because of duplicate content and 404s Disallow: /SimpleSignOn.modal Disallow: /*.raw$ Disallow: /includes/ Disallow: /installation/ Disallow: /language/ Disallow: /libraries/ Disallow: /logs/ Disallow: /tmp/ Disallow: /usr/local/apache/htdocs/ Disallow: /usr/bin/php User-agent: Googlebot-Image crawl-delay: 10 Allow: /images/ Allow: /media/ User-agent: Mediapartners-Google crawl-delay: 10 Disallow: /administrator/ Disallow: /cache/ Disallow: /cli/ Disallow: /includes/ Disallow: /installation/ Disallow: /language/ Disallow: /libraries/ Disallow: /logs/ Disallow: /tmp/ Disallow: /usr/local/apache/htdocs/ Disallow: /usr/bin/php # JSitemap entries Sitemap: http://www.urotoday.com/index.php?option=com_jmap&view=sitemap&format=xml Sitemap: http://www.urotoday.com/index.php?option=com_jmap&view=sitemap&format=images # Sitemap: http://www.urotoday.com/index.php?option=com_jmap&view=sitemap&format=mobile Sitemap: http://www.urotoday.com/index.php?option=com_jmap&view=sitemap&format=gnews #User-agent: msnbot #Disallow: / #User-agent: Yandex #Disallow: / User-agent: Baiduspider User-agent: Naver User-agent: Majestic-12 User-agent: Majestic-SEO User-agent: Slurp User-agent: AhrefsBot User-Agent: MJ12bot Disallow: / User-Agent: SEMrushBot-Desktop crawl-delay: 10 Disallow: /SimpleSignOn.modal Disallow: /*.raw$ # [email protected] may 8th 2025 # # # Amazon Bot - enabling Alexa to answer even more questions for customers. User-agent: Amazonbot Disallow: / # Anthropic AI Bot User-agent: anthropic-ai Disallow: / # Apple Bot - collects website data for its Siri and Spotlight services. User-agent: Applebot Disallow: / # Claude Bot run by Anthropic User-agent: Claude-Web Disallow: / # Cohere AI Bot - unconfirmed bot believed to be associated with Cohere’s chatbot. User-agent: cohere-ai Disallow: / # Common Crawl's bot - Common Crawl is one of the largest public datasets used by AI for training, with ChatGPT, Bard and other large language models. User-agent: CCBot Disallow: / # Diffbot - somewhat dishonest scraping bot used to collect data to train LLMs. User-agent: Diffbot Disallow: / # ImagesiftBot is billed as a reverse image search tool, but it's associated with The Hive, a company that produces models for image generation. User-agent: ImagesiftBot Disallow: / # KUKA's youBot User-agent: YouBot Disallow: / # OMGilibot - They sell data for training LLMs (large language models) User-agent: omgilibot Disallow: / # Omgili (Oh My God I Love It) User-agent: omgili Disallow: / # OpenAI API - bot that OpenAI specifically uses to collect bulk training data from your website for ChatGPT. User-agent: GPTBot Disallow: / # Perplexity AI User-agent: PerplexityBot Disallow: / ## Social Media Bots # Bytespider is a web crawler operated by ByteDance, the Chinese owner of TikTok User-agent: Bytespider Disallow: / # Meta’s bot that crawls public web pages to improve language models for their speech recognition technology User-agent: FacebookBot Disallow: /
Se han encontrado las siguientes palabras clave. Comprueba si esta página está bien optimizada para cada palabra clave en concreto.
Palabra clave | Resultado | Comprobar |
---|---|---|
Urology | 68% | Check |
GU Oncology | 64% | Check |
Oncology | 63% | Check |
Urology GU Oncology | 63% | Check |
Monotherapy or | 54% | Check |
Urology Clinics | 54% | Check |
or Chemotherapy | 54% | Check |
or Metastatic Urothelial Cancer | 52% | Check |
Urologic Oncology | 51% | Check |
Advanced or Metastatic | 51% | Check |
PSMA PET CT | 51% | Check |
2025 coverage | 51% | Check |
Roger Li | 50% | Check |
PET CT | 50% | Check |
Cancer | 49% | Check |
Bladder | 49% | Check |
Bladder Cancer | 49% | Check |
PSMA | 49% | Check |
Advanced Bladder Cancer | 49% | Check |
PSMA 2025 | 49% | Check |
Bladder Cancer Treatment | 49% | Check |
Bladder Cancer AUA | 49% | Check |
Advanced or Metastatic Urothelial | 49% | Check |
ASCO GU | 49% | Check |
Prostate Cancer | 48% | Check |
Selecciona una forma de contacto
Opciones de contacto
Envíanos un e-mail a [email protected]
Llámanos al
+49 911 23756261
De Lunes a Viernes (CET)
de 9 am a 5 pm
¿No encuentras lo que buscas? También puedes descargarte la Guía: Primeros pasos, visitar la sección de Preguntas frecuentes, nuestra Wiki SEO: conocimientos básicos o nuestro Blog.
Selecciona una forma de contacto
Hemos recibido tu mensaje y te contestaremos lo antes posible.
Utilizamos cookies para el buen funcionamiento de nuestra web y con fines analíticos y publicitarios. Puedes activar o desactivar las cookies opcionales. Para más información consulta los siguientes enlaces.
Utilizamos estas cookies para que el sitio funcione correctamente
Con estas cookies podemos entender mejor cómo navegan las y los visitantes por nuestra web
Estas cookies nos ayudan a ofrecerte anuncios y promociones que se ajusten a tus intereses
(Deseable)